<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="mend"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3607698/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607698/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Molecular Endocrinology"><meta name="citation_title" content="TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression"><meta name="citation_authors" content="Mohan Liu, James N. Ingle, Brooke L. Fridley, Aman U. Buzdar, Mark E. Robson, Michiaki Kubo, Liewei Wang, Anthony Batzler, Gregory D. Jenkins, Tracy L. Pietrzak, Erin E. Carlson, Matthew P. Goetz, Donald W. Northfelt, Edith A. Perez, Clark V. Williard, Daniel J. Schaid, Yusuke Nakamura, Richard M. Weinshilboum"><meta name="citation_date" content="April 2013"><meta name="citation_issue" content="4"><meta name="citation_volume" content="27"><meta name="citation_firstpage" content="657"><meta name="citation_doi" content="10.1210/me.2012-1397"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3607698/?report=abstract"><meta name="citation_pmid" content="23518928"><meta name="DC.Title" content="TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="The Endocrine Society"><meta name="DC.Contributor" content="Mohan Liu"><meta name="DC.Contributor" content="James N. Ingle"><meta name="DC.Contributor" content="Brooke L. Fridley"><meta name="DC.Contributor" content="Aman U. Buzdar"><meta name="DC.Contributor" content="Mark E. Robson"><meta name="DC.Contributor" content="Michiaki Kubo"><meta name="DC.Contributor" content="Liewei Wang"><meta name="DC.Contributor" content="Anthony Batzler"><meta name="DC.Contributor" content="Gregory D. Jenkins"><meta name="DC.Contributor" content="Tracy L. Pietrzak"><meta name="DC.Contributor" content="Erin E. Carlson"><meta name="DC.Contributor" content="Matthew P. Goetz"><meta name="DC.Contributor" content="Donald W. Northfelt"><meta name="DC.Contributor" content="Edith A. Perez"><meta name="DC.Contributor" content="Clark V. Williard"><meta name="DC.Contributor" content="Daniel J. Schaid"><meta name="DC.Contributor" content="Yusuke Nakamura"><meta name="DC.Contributor" content="Richard M. Weinshilboum"><meta name="DC.Date" content="2013 Apr"><meta name="DC.Identifier" content="10.1210/me.2012-1397"><meta name="DC.Language" content="en"><meta property="og:title" content="TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression"><meta property="og:type" content="article"><meta property="og:description" content="We performed a discovery genome-wide association study to identify genetic factors associated with variation in plasma estradiol (E2) concentrations using DNA from 772 postmenopausal women with estrogen receptor (ER)-positive breast cancer prior to the ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607698/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-mend.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3607698/epub/">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE888363DD555BD100000000055D0371.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3607698%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="clinvar">ClinVar</option><option value="gene" class="last">Gene</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22Mol Endocrinol%22[journal]" class="navlink">Mol Endocrinol</a></li><li class="accid">PMC3607698</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-mend.gif" alt="Logo of mend" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="430,0,484,75" alt="Archive" title="Archive" href="http://mend.endojournals.org/contents-by-date.0.shtml" ref="reftype=publisher&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="215,5,377,47" alt="Homepage" title="Homepage" href="http://mend.endojournals.org/" ref="reftype=publisher&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="8,1,176,75" alt="TES Homepage" title="TES Homepage" href="http://www.endo-society.org/" ref="reftype=publisher&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="331,56,405,75" alt="Subscriptions" title="Subscriptions" href="http://mend.endojournals.org/subscriptions/" ref="reftype=publisher&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="256,56,330,75" alt="Submission" title="Submission" href="https://www.rapidreview.com/tes/CALogon.jsp" ref="reftype=publisher&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="181,56,255,75" alt="About" title="About" href="http://www.endojournals.org/" ref="reftype=publisher&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Mol Endocrinol</a></span>. 2013 Apr; 27(4): 657–670. </span></div><div><span class="fm-vol-iss-date">Published online 2013 Mar 21. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1210%2Fme.2012-1397" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1210/me.2012-1397</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3607698</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/23518928">23518928</a></div></div></div></div><h1 class="content-title">TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Liu%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Mohan Liu</a>,<sup>*</sup> <a href="/pubmed/?term=Ingle%20JN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">James N. Ingle</a>,<sup>*</sup> <a href="/pubmed/?term=Fridley%20BL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Brooke L. Fridley</a>, <a href="/pubmed/?term=Buzdar%20AU%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Aman U. Buzdar</a>, <a href="/pubmed/?term=Robson%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Mark E. Robson</a>, <a href="/pubmed/?term=Kubo%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Michiaki Kubo</a>, <a href="/pubmed/?term=Wang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Liewei Wang</a>, <a href="/pubmed/?term=Batzler%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Anthony Batzler</a>, <a href="/pubmed/?term=Jenkins%20GD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Gregory D. Jenkins</a>, <a href="/pubmed/?term=Pietrzak%20TL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Tracy L. Pietrzak</a>, <a href="/pubmed/?term=Carlson%20EE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Erin E. Carlson</a>, <a href="/pubmed/?term=Goetz%20MP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Matthew P. Goetz</a>, <a href="/pubmed/?term=Northfelt%20DW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Donald W. Northfelt</a>, <a href="/pubmed/?term=Perez%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Edith A. Perez</a>, <a href="/pubmed/?term=Williard%20CV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Clark V. Williard</a>, <a href="/pubmed/?term=Schaid%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Daniel J. Schaid</a>, <a href="/pubmed/?term=Nakamura%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Yusuke Nakamura</a>, and  <a href="/pubmed/?term=Weinshilboum%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23518928">Richard M. Weinshilboum</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140707388011040_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140707388011040_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140707388011040_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140707388011040_ai" style="display:none"><div class="fm-affl" id="idm140707384510576" lang="en">Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics (M.L., L.W., R.M.W.), Department of Oncology (J.N.I., M.P.G.), Department of Health Sciences Research (B.L.F., A.B., G.D.J., E.E.C., D.J.S.), Mayo Clinic, Rochester, Minnesota 55905; Department of Breast Oncology (A.U.B.), M.D. Anderson Cancer Center, Houston, Texas 77030; Breast Medicine Service (M.E.R), Memorial Sloan Kettering Cancer Center, New York, New York 10021; RIKEN Center for Genomic Medicine (M.K.), Yokohama City, Japan; Research Application Solutions Unit, Information Technology (T.L.P.), Mayo Clinic, Rochester, Minnesota 55905; Division of Hematology/Oncology (D.W.N.), Mayo Clinic, Scottsdale, Arizona 85259; Division of Hematology/Oncology (E.A.P.), Mayo Clinic, Jacksonville, Florida 32224; PharmaNet USA (C.V.W.), Inc., Princeton, New Jersey 08540; and Department of Medicine (Y.N.), Chicago University, School of Medicine, Chicago, Illinois 60637</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup>Corresponding author.</div><div id="idm140707384509200">Address all correspondence and requests for reprints to: Richard Weinshilboum, M.D., Mayo Clinic 200 First Street SW, Rochester, Minnesota 55905.,  E-mail: <a href="mailto:dev@null" data-email="ude.oyam@drahcir.muoblihsniew" class="oemail">ude.oyam@drahcir.muoblihsniew</a>.</div><div id="FN1"><sup>*</sup>M.L. and J.N.I. contributed equally to this work.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140707388011040_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2012 Dec 11; Accepted 2013 Feb 20.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140707388011040_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  © 2013 by The Endocrine Society</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3607698/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140707427392976" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140707427392976title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first">We performed a discovery genome-wide association study to identify genetic factors associated with variation in plasma estradiol (E2) concentrations using DNA from 772 postmenopausal women with estrogen receptor (ER)-positive breast cancer prior to the initiation of aromatase inhibitor therapy. Association analyses showed that the single nucleotide polymorphisms (SNP) (rs1864729) with the lowest <em>P</em> value (<em>P</em> = 3.49E-08), mapped to chromosome 8 near <em>TSPYL5</em>. We also identified 17 imputed SNPs in or near <em>TSPYL5</em> with <em>P</em> values &lt; 5E-08, one of which, rs2583506, created a functional estrogen response element. We then used a panel of lymphoblastoid cell lines (LCLs) stably transfected with ERα with known genome-wide SNP genotypes to demonstrate that <em>TSPYL5</em> expression increased after E2 exposure of cells heterozygous for variant <em>TSPYL5</em> SNP genotypes, but not in those homozygous for wild-type alleles. <em>TSPYL5</em> knockdown decreased, and overexpression increased aromatase (CYP19A1) expression in MCF-7 cells, LCLs, and adipocytes through the skin/adipose (I.4) promoter. Chromatin immunoprecipitation assay showed that TSPYL5 bound to the <em>CYP19A1</em> I.4 promoter. A putative <em>TSPYL5</em> binding motif was identified in 43 genes, and TSPYL5 appeared to function as a transcription factor for most of those genes.</p><p id="__p3" class="p p-last">In summary, genome-wide significant SNPs in <em>TSPYL5</em> were associated with elevated plasma E2 in postmenopausal breast cancer patients. SNP rs2583506 created a functional estrogen response element, and LCLs with variant SNP genotypes displayed increased E2-dependent <em>TSPYL5</em> expression. TSPYL5 induced <em>CYP19A1</em> expression and that of many other genes. These studies have revealed a novel mechanism for regulating aromatase expression and plasma E2 concentrations in postmenopausal women with ER(+) breast cancer.</p></div></div><div id="idm140707388336976" class="tsec sec headless whole_rhythm"><p id="__p4" class="p p-first">Circulating estradiol (E2) concentrations decrease dramatically after menopause, but final postmenopausal hormone levels show large individual variation (<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775158">1</a>). This variation has many potential causes, but it may result, in part, from functionally significant sequence variation in genes encoding proteins involved in estrogen biosynthesis, transport, and metabolism (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775170">2</a>). Variation in plasma E2 concentrations is associated with risk for diseases that range from breast cancer to osteoporosis (<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775146">3</a>). Before menopause, most circulating estrogen is produced in the ovary (<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775173">4</a>). However, after menopause, adipose tissue becomes the predominant source of estrogens (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775152">2</a>). It is known that estrogens can influence the expression of the aromatase (<em>CYP19A1</em>) gene, which encodes the cytochrome P450 isoform that catalyzes the synthesis of estrone (E1) and E2 from androstenedione and testosterone, respectively (<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775155">5</a>). <em>CYP19A1</em> maps to chromosome 15 q21.1 and contains multiple upstream promoters and exons that encode 5′-untranslated region (5′-UTR) sequences, which are differentially expressed in various tissues/cell types, including adipose tissue, skin, and bone (<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775174">6</a>). Single nucleotide polymorphisms (SNPs) in the <em>CYP19A1</em> gene have been associated with variation in circulating estrogen concentrations and with breast cancer risk (<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775143">7</a>, <a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775156">8</a>).</p><p id="__p5">The present study was performed in an attempt to identify novel genes that might influence circulating concentrations of E2 in postmenopausal women who recently underwent surgical resection for early stage estrogen receptor positive [ER(+)] breast cancer and who were candidates for adjuvant aromatase inhibitor therapy. Specifically, we obtained DNA and plasma before the initiation of aromatase inhibitor therapy to assay circulating E2 levels and to perform a discovery genome-wide association study (GWAS) for polymorphisms associated with plasma E2 concentrations. Of importance is the fact that we used a sensitive gas chromatography negative ionization tandem mass spectrometry (GC-MS/MS) E2 assay because our study population comprised postmenopausal women who already had decreased circulating E2 concentrations, and we planned to decrease those levels further by aromatase inhibitor therapy. The patients in this study were all breast cancer patients, but they were not receiving any treatment for breast cancer, although a small number had previously received tamoxifen well before blood samples were obtained for this study. The GWAS identified SNPs on chromosome 8 that mapped 3′ to the <em>TSPYL5</em> gene and were associated with increased plasma E2 concentrations. <em>TSPYL5</em> encodes “testis-specific Y-encoded-like protein 5”, a known breast cancer risk gene as well as a marker for poor outcomes in breast cancer patients (<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775168">9</a>). However, very little is known with regard to the biologic function of this protein, and there have been no previous reports of an association between <em>TSPYL5</em> and circulating E2 concentrations.</p><p id="__p6" class="p">During our pursuit of possible mechanisms that might explain this association, we observed that the variant allele for one of the E2-associated SNPs near <em>TSPYL5</em> created a functional estrogen response element (ERE). We then took advantage of a genomic data-rich lymphoblastoid cell line (LCL)-based model system that has already proved to be a powerful tool both for generating pharmacogenomic hypothesis (<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775160">8</a>, <a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775142">10</a>) and for the functional pursuit of GWAS signals (<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775169">11</a>). Although, like all model systems, these LCLs have limitations, we cannot overemphasize the practical utility of this cell line model system for making it possible to link variation in genotype with variation in biochemical and molecular phenotypes. Specifically, we used the LCLs to show that variant chromosome 8 <em>TSPYL5</em> SNP sequences were associated with increased <em>TSPYL5</em> expression after exposure to E2 and, of direct relevance to the phenotype studied in the GWAS, that increased <em>TSPYL5</em> expression was associated with increased expression of <em>CYP19A1</em>. We also demonstrated that TSPYL5 binds to a DNA sequence motif in the <em>CYP19A1</em> I.4 “adipose tissue” promoter. When we scanned the genome with that DNA sequence motif, it was present 5′ of or within a number of genes, most of which were regulated in parallel with TSPYL5, as demonstrated by TSPYL5 knockdown or overexpression in adipocytes as well as MCF-7, IMR-90, and human embryonic kidney (HEK)293T cells. Furthermore, TSPYL5 bound to most these sequence motifs, as demonstrated by chromatin immunoprecipitation (ChIP) assay. Therefore, this series of experiments not only identified novel SNP biomarkers for plasma E2 levels in postmenopausal breast cancer patients but also a new transcription factor, TSPYL5, that appears to participant in the regulation of the expression of <em>CYP19A1</em> as well as a number of other genes.</p></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Materials and Methods</h2><div id="__sec2" class="sec sec-first"><h3 id="__sec2title">Source of patients</h3><p id="__p7" class="p p-first-last">The study that was the source of our patients had enrolled postmenopausal women with resected early-stage breast cancer at the Mayo Clinic (Rochester, Minnesota, Jacksonville, Florida, and Scottsdale, Arizona), M.D. Anderson Cancer Center, and Memorial Sloan-Kettering Cancer Center. Eligibility criteria included postmenopausal status, stage I, II, or III breast cancer according to the American Joint Committee on Cancer (AJCC) Staging Manual (Sixth Edition), tumor that was ER and/or progesterone receptor (PgR) positive and planned treatment with the aromatase inhibitor anastrozole at the clinically approved dose of 1 mg per day. Patients could have already received tamoxifen, but prior exposure to other endocrine therapy was not permitted. None of the patients were receiving hormone replacement therapy at the time of the study. Two weeks or less before the initiation of anastrozole therapy, a blood sample was obtained for the isolation of DNA and for the assay of pretreatment plasma E2 concentrations. This study was reviewed and approved by local institutional review boards at all participating institutions. Written informed consent was obtained from each patient.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Hormone assays</h3><p id="__p8" class="p p-first">A highly validated GC-MS/MS assay was used to measure E2 concentrations in 1.0 mL of human plasma (<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775171">12</a>). The lower limit of quantitation (LLQ) for E2 with this assay was 0.625 pg/mL. The standard used for the assay was &gt; 98% pure E2 purchased from Steraloids (Newport, Rhode Island). For each batch of samples analyzed, two standard curves (“front” and “back”, with eight different E2 concentration levels in each standard curve) were prepared in water and quantified together with quality control (QC) samples (two replicates at low, mid, and high concentrations) prepared in charcoal-stripped plasma. Analytic runs were accepted when more than 75% of standards had back-calculated concentrations within ±15% of nominal. However, at the LLQ, ±20% of nominal concentrations was accepted. Quality control samples met accuracy requirements when they fell within ±15% of their nominal concentrations.</p><p id="__p9" class="p p-last">Specifically, E2 and its deuterated internal standard were extracted from 1 mL of plasma using Bond Elut Certify (Varian) solid-phase extraction cartridges. E2 was then eluted with ethyl acetate and was derivitized with pentafluorobenzoyl chloride and <em>N</em>-methyl-<em>N</em>-(trimethylsilyl)trifluoroacetamide. All solvents and reagents were purchased from EMD Product (Charlotte, North Carolina) or Sigma-Aldrich (St. Louis, Missouri). The derivatized analytes were separated on a Varian 3400 gas chromatograph (Block Scientific, Bohemia, New York) equipped with a DB-17-fused silica capillary column (15 m × 0.025 mm, J&amp;W Scientific, Folsom, California) and were quantified using an interfaced Finnigan MAT TSQ-700 mass spectrometer (Finnigan MAT, Bremen, Germany) operating in single-ion monitoring tandem mass spectrometry-negative ion chemical ionization mode.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">GWAS genotyping</h3><p id="__p10" class="p p-first-last">Genotypes for DNA samples extracted from blood were determined at the RIKEN Center for Genomic Medicine in Yokahama, Japan, with Illumina Human610-Quad BeadChips. Illumina BeadStudio was used to call genotypes, and a series of QC parameters (see Supplemental Methods published on The Endocrine Society's Journals Online web site at <a href="http://mend.endojournals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://mend.endojournals.org</a>) was applied to exclude ambiguous calls.</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Statistical analyses</h3><div id="__sec6" class="sec sec-first-last"><h4 id="__sec6title">GWAS genotype QC</h4><p id="__p11" class="p p-first-last">Before analysis for associations between SNP genotypes and plasma E2 concentrations, extensive genotype QC was performed. Of the 835 samples initially genotyped, two had insufficient DNA; one sample failed genotyping; and one was removed because of questionable gender, leaving 831 samples. For the four duplicate samples studied, there were only 21 discordant SNP genotypes among the 2 368 944 comparisons made. For Centre d'Etude du Polymorphism Humain (CEPH) trios that were used as an additional control, there were 276 Mendelian errors out of the 592 236 genotypes evaluated. These results indicate excellent genotype quality. After removing the four subjects described previously, QC was completed for the 831 remaining subjects and the 592 236 SNPs that had been genotyped. SNPs were removed if they failed genotyping (12 849 SNPs), had a call rate less than 95% (0 SNPs), had minor allele frequencies (MAFs) less than 1% (15 282 SNPs), or had Hardy-Weinberg equilibrium (HWE) <em>P</em> value &lt; 1E-06 (160 SNPs). This QC process resulted in a final total of 563 945 SNPs that were included in the association analysis.</p></div></div><div id="__sec7" class="sec"><h3 id="__sec7title">Population stratification</h3><p id="__p12" class="p p-first-last">Rather than relying on self-reported race, we used the genome-wide SNP data to determine three major racial groups, Caucasian, African American, and Han Chinese, based on the program STRUCTURE (<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775161">13</a>). This SNP data were obtained by genome-wide genotyping of Coriell Institute “Human Variation Panel” lymphoblastoid cell lines (LCLs), as described previously (<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775153">14</a>). These SNP data were used to “anchor” the STRUCTURE analysis. Patients were assigned to a racial group if their probability of falling into that group was more than 50%. One subject of ambiguous race was removed from the analysis (ie, the probability was &lt; 0.50 for all three racial groups). To avoid bias that might arise from genetic substructure within racial groups, an eigen analysis was performed within each racial group using EIGENSTRAT (<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775162">15</a>). Eigenvectors corresponding to eigenvalues determined to be statistically different from zero based on the Tracy-Widom test were included as covariates in the analysis (<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775141">16</a>). This resulted in the inclusion of six eigenvectors in the model to adjust for substructure and population stratification.</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Association analysis</h3><p id="__p13" class="p p-first-last">Association analysis for plasma E2 concentrations was performed with each SNP genotype using an additive genetic model (ie, trend test in terms of number of minor alleles) for the 772 women who had plasma E2 and genotypic data that passed QC. In addition to the inclusion of race and eigenvectors in the model, we also included body mass index (BMI), age at enrollment, study site, prior chemotherapy, and ER/PgR status. BMI is known to be highly associated with level of E2 (<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775149">17</a>). If the value for the E2 concentration fell below the LLQ, the E2 concentration was set to zero. Because of skewness in the distribution of E2 concentrations and a large number of zero values, a quasi-likelihood model was used, in which the relationship between the mean and variance was modeled as Variance (X) = Expectation (X) (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775166">2</a>) (ie, an overdispersed model) (<a href="#B18" rid="B18" class=" bibr popnode">18</a>, <a href="#B19" rid="B19" class=" bibr popnode">19</a>). Additional information on model diagnostics is included in <em>Results</em>. Unless otherwise stated, all statistical analyses were conducted using the R statistical computing package SAS or PLINK (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775145">20</a>).</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">Imputation and fine mapping</h3><p id="__p14" class="p p-first">SNPs that had not been genotyped were imputed within 200 kb of the top associated SNP on chromosome 8, rs1864729, with BEAGLE v3.3.1 (<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775157">21</a>). Imputation was completed for all subjects using the entire set of haplotypes from the 1000 Genomes Project (<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775148">22</a>) from the 11/23/2010 release (N = 1094 subjects). Imputed markers with a quality score R<sup>2</sup> &lt; 0.30 or MAF &lt; 0.01 were removed from the analyses. Association analysis for plasma E2 concentrations was then performed using the expected minor allele count or “dosage” with the same quasi-likelihood model used to analyze the genotyped SNP markers.</p><p id="__p15" class="p p-last">Forty-five imputed SNPs from the region in and near TSPYL5 as well as two SNPs in <em>CYP19A1</em> were then genotyped at the RIKEN Center for Genomic Medicine using Invader technology. Six of these SNPs had also been genotyped on the Illumina array, providing an additional level of QC. Quality control and association analysis for these “fine-mapped” SNPs was performed using the approach that was used for the SNPs on the Illumina BeadChip array. Fourteen subjects with call rates less than 98% were removed from the fine-mapping analysis. Call rates for the fine mapped SNPs were greater than 99%, with only four discrepant calls (for rs2116422) between Illumina and Invader genotypes. These four discrepant genotype calls were treated as “missing” during the association analysis.</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">LCL transfection and culture</h3><p id="__p16" class="p p-first-last">Three LCLs heterozygous for variant genotypes for the rs2583506 and rs1864729 SNPs, as well as three LCLs homozygous for WT sequences at these SNPs, were stably transfected with a pcDNA4.1-ERα construct provided by Dr. Thomas Spelsberg (Mayo Clinic, Rochester, Minnesota). Genotypes for the rs2583506 SNP in these six cell lines were confirmed by the amplification of genomic DNA using the following primers: forward, 5′-CATCACAACCTCACCCACAT-3′; reverse, 5′-CTGTCAGCTCTAGC CCCTTG-3′. These amplicons were sequenced using Sanger DNA sequencing as described previously (<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775164">23</a>). Genotypes for the rs1864729 SNP in these cells had been determined previously during GWAS genotyping. These six LCLs were then cultured in RPMI media containing 15% (vol/vol) fetal bovine serum (FBS) with 200 μg/mL Zeocin (Invitrogen, Grand Island, New York). Before E2 treatment, 2 × 10<sup>7</sup> cells for each cell line were cultured for 24 hours in RPMI containing 5% (vol/vol) charcoal-stripped FBS with 200 μg/ml G418 (Invitrogen), followed by culture in the same medium without FBS for an additional 24 hours. All cells were then cultured for 24 hours in 12-well plates with RPMI 1640 medium that contained 0, 0.00001, 0.0001, 0.001, and 0.01 nM E2, and total RNA was isolated from the cells with the RNeasy mini kit (QIAGEN, Valencia, California). Total RNA (200 ng) was then used to perform quantitative RT-PCR (qRT-PCR) with TSPYL5, CYP19A1, and ERα primers (QIAGEN). TSPYL5 and CYP19A1 expression levels were “normalized” in each of the cell lines studied on the basis of ERα expression. Primers used to perform the <em>CYP19A1</em> promoter amplifications are listed in Supplemental Table 1.</p></div><div id="__sec11" class="sec"><h3 id="__sec11title">ChIP</h3><p id="__p17" class="p p-first-last">ChIP assays were performed using the Imprint Ultra Chromatin Immunoprecipitation Kit (Sigma, St. Louis, Missouri). Both quantitative PCR and standard agarose gel-based PCR were used to monitor the ChIP results. PCRs contained 1.25 U of <em>Taq</em> polymerase enzyme (Promega Corp., Madison, Wisconsin), 1× reaction buffer, 1.5 mM MgCl<sub>2</sub>, 0.5 mM deoxynucleotide triphosphate (Invitrogen), 357 nM primers, and 2 μL of DNA from the ChIP assay in a final volume of 50 μL. PCR products (20 μl) were loaded on 1.2% agarose gels, and electrophoresis was performed at 100 V for 1.5 hours in 1× TAE buffer.</p></div><div id="__sec12" class="sec sec-last"><h3 id="__sec12title">TSPYL5 knockdown and overexpression</h3><p id="__p18" class="p p-first-last">HO3sD-96Wa differentiated adipocytes were obtained from Cell Applications, Inc. (San Diego, California). MCF-7, IMR-90, and HEK293T cells were obtained from American Type Culture Collection (ATCC, Manassas, Virginia), and all four cell lines were transfected with a TSPYL5 small interfering RNA (siRNA) smart pool (Dharmacon, Lafayette, Colorado) and FuGENE 6 (Roche, Indianapolis, Indianapolis) using lipofectamine iMAX (Invitrogen) for “knock down” studies or with 2 μg of pCMV6-XL4-TSPYL5 or pCMV6-XL4 as a control for TSPYL5 overexpression. Total RNA was isolated from the transfected HO3sD-96Wa, MCF-7, IMR-90, and HEK293T cells using the Quick RNA mini-prep kit (Zymo Research, Irvine, California), and 100 ng of total RNA was used to perform qRT-PCR with primers (IDT, Coralville, Iowa) for all 43 genes that were found to contain the TSPYL5 DNA-binding motif as were primers (QIAGEN) for TSPYL5 and β-actin. Proteins from transfected MCF-7 cells were extracted using CelLytic M Cell Lysis buffer (Sigma-Aldrich), were separated by electrophoresis on 4%–20% SDS-PAGE gels, and were transferred to polyvinylidene difluoride membranes (Bio-Rad Laboratories, Inc., Hercules, California). The polyvinylidene difluoride membranes were probed with anti-TSPYL5 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, California) diluted 1:1500 in 1% condensed milk blocking buffer or with anti-CYP19A1 antibody (Santa Cruz Biotechnology) diluted 1:1000 in blocking buffer. Protein bands were visualized using enhanced chemiluminescence (Thermo Scientific, Rockford, IL). An antiactin monoclonal antibody (Sigma) at a dilution of 1:5000 was used to detect actin.</p></div></div><div id="__sec13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec13title">Results</h2><div id="__sec14" class="sec sec-first"><h3 id="__sec14title">GWAS for plasma E2 concentrations</h3><p id="__p19" class="p p-first">Our GWAS involved 772 women with early-stage breast cancer from whom blood samples for plasma hormone assay and DNA isolation had been obtained. Demographic and clinic data for these patients are listed in <a href="/pmc/articles/PMC3607698/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. After genome-wide SNP genotyping and QC, a total of 563 945 SNPs were included in the analysis. <a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>A is a Manhattan plot showing the associations for these 563 945 SNPs with plasma E2 concentrations.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p id="__p20">Patient Characteristics (n = 772)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707389065424" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">Source</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="left">Tumor ER/PgR Status</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    MCR</td><td rowspan="1" colspan="1" align="center">182 (23.6%)</td><td rowspan="1" colspan="1" align="left">    Negative/positive</td><td rowspan="1" colspan="1" align="center">7 (0.9%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    MCF</td><td rowspan="1" colspan="1" align="center">32 (4.1%)</td><td rowspan="1" colspan="1" align="left">    Positive/negative</td><td rowspan="1" colspan="1" align="center">152 (19.7%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    MCA</td><td rowspan="1" colspan="1" align="center">78 (10.1%)</td><td rowspan="1" colspan="1" align="left">    Positive/positive</td><td rowspan="1" colspan="1" align="center">612 (79.3%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    MDA</td><td rowspan="1" colspan="1" align="center">348 (45.1%)</td><td rowspan="1" colspan="1" align="left">    Positive/unknown<sup>a</sup></td><td rowspan="1" colspan="1" align="center">1 (0.1%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    MSK</td><td rowspan="1" colspan="1" align="center">132 (17.1%)</td><td rowspan="1" colspan="1" align="left">Tumor HER2 Status</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">Age at time of study (years)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="left">    Negative</td><td rowspan="1" colspan="1" align="center">667 (86.4%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    Mean (<span class="small-caps">sd</span>)</td><td rowspan="1" colspan="1" align="center">67.2 (9.5)</td><td rowspan="1" colspan="1" align="left">    Positive</td><td rowspan="1" colspan="1" align="center">91 (11.8%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    Median</td><td rowspan="1" colspan="1" align="center">66.8</td><td rowspan="1" colspan="1" align="left">    Unknown</td><td rowspan="1" colspan="1" align="center">14 (1.8%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    Range</td><td rowspan="1" colspan="1" align="center">(39.1–95.4)</td><td rowspan="1" colspan="1" align="left">Smoking Status</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">Self-defined race</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="left">    No</td><td rowspan="1" colspan="1" align="center">718 (93%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    European</td><td rowspan="1" colspan="1" align="center">700 (90.7%)</td><td rowspan="1" colspan="1" align="left">    Yes</td><td rowspan="1" colspan="1" align="center">43 (5.6%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    African</td><td rowspan="1" colspan="1" align="center">50 (6.4%)</td><td rowspan="1" colspan="1" align="left">    Unknown</td><td rowspan="1" colspan="1" align="center">11 (1.4%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    Asian</td><td rowspan="1" colspan="1" align="center">17 (2.2%)</td><td rowspan="1" colspan="1" align="left">Prior Chemotherapy</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Native American</td><td rowspan="1" colspan="1" align="center">5 (0.6%)</td><td rowspan="1" colspan="1" align="left">    No</td><td rowspan="1" colspan="1" align="center">461 (59.7%)</td></tr><tr><td rowspan="1" colspan="1" align="left">Self-defined ethnicity</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="left">    Yes</td><td rowspan="1" colspan="1" align="center">311 (40.3%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    Hispanic</td><td rowspan="1" colspan="1" align="center">65 (8.4%)</td><td rowspan="1" colspan="1" align="left">Prior Tamoxifen</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Non-Hispanic</td><td rowspan="1" colspan="1" align="center">699 (90.5%)</td><td rowspan="1" colspan="1" align="left">    No</td><td rowspan="1" colspan="1" align="center">690 (89.4%)</td></tr><tr><td rowspan="1" colspan="1" align="left">    Unknown</td><td rowspan="1" colspan="1" align="center">8 (1.0%)</td><td rowspan="1" colspan="1" align="left">    Yes</td><td rowspan="1" colspan="1" align="center">82 (10.6%)</td></tr><tr><td rowspan="1" colspan="1" align="left">BMI</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Mean (SD)</td><td rowspan="1" colspan="1" align="center">27.9 (6.20)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Median</td><td rowspan="1" colspan="1" align="center">27.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Range</td><td rowspan="1" colspan="1" align="center">(16.0–57.2)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140707389065424" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3607698/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140707386577968"><p id="__p21" class="p p-first-last">The table lists demographic data for the 772 breast cancer patients included in this study. MCR, Mayo Clinic Rochester; MCF, Mayo Clinic Florida; MCA, Mayo Clinic Arizona; MDA, MD Anderson Cancer Center; MSK, Memorial Sloan Kettering Cancer Center.</p></div><div id="TF1-1"><sup>a</sup> The Positive/Unknown sample was grouped with the Positive/Positive tumors for the statistical analysis.</div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707393457280" class="figure"><a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3607698_zmg0041351770001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3607698/bin/zmg0041351770001.jpg"></a></div><div id="largeobj_idm140707393457280" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3607698/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3607698/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1.</a></div><!--caption a7--><div class="caption"><p id="__p23">A, Manhattan Plot of GWAS for plasma E2 Concentrations. The figure shows the results of conditional regression analysis adjusted for eight eigenvectors. B, The chromosome 8 region surrounding the <em>TSPYL5</em> gene from the Manhattan plot showing a plot of −log10 (<em>P</em> value) for observed (circles), imputed (diamonds), as well as imputed and then genotyped (red circles) SNPs. The location of the <em>TSPYL5</em> gene is also indicated. C, A Q-Q plot is shown of observed vs expected results under the null hypothesis of no SNP association with plasma E2 concentrations.</p></div></div></div><p id="__p24">The lowest <em>P</em> value observed was 3.49E-08, achieving the nominal value of 5E-08 required for genome-wide significance (<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775150">24</a>). A QQ plot of observed vs expected results under the null hypothesis of no association is shown in <a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>C. The inflation factor was λ = 1.028 where an estimate of 1.0 indicates no inflation in the distribution of the test statistics. Acceptable levels of λ tend to be less than 1.05. Even though an inflation factor of 1.028 would be considered acceptable, we observed a slight inflation at the extreme tail of the QQ plot. Further investigation demonstrated that this was due to the top 1% of associated SNPs (see Supplemental Statistical Analysis Material for additional details), indicating a possible polygenic inheritance model (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775159">25</a>).</p><p id="__p25" class="p">The top 25 SNPs most highly associated with plasma E2 concentrations that were genotyped using the Illumina platform are listed in <a href="/pmc/articles/PMC3607698/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>. Three of the top 10 genotyped SNPs, including the two SNPs with the lowest <em>P</em> values, 3.49E-08 and 6.49E-08, mapped to chromosome 8 near the <em>TSPYL5</em> gene. Subsequent imputation across this area of chromosome 8 revealed a total of 17 additional SNPs with <em>P</em> values &lt; 5E-08 (<a href="/pmc/articles/PMC3607698/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> and <a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>B). All imputed chromosome 8 SNPs with low <em>P</em> values were then also genotyped, and the data shown in <a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>B and listed in <a href="/pmc/articles/PMC3607698/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> for those SNPs are based on the genotyped data. All of the <em>TSPYL5</em> SNPs with <em>P</em> values &lt; 1E-08 were in high linkage disequilibrium or correlation (r<sup>2</sup> &gt; 0.9), and all had a MAF of approximately 0.10 (<a href="/pmc/articles/PMC3607698/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a> and <a href="/pmc/articles/PMC3607698/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p id="__p26">Top 25 Genotyped SNPs Most Highly Associated with Plasma E2 Concentrations</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707388541504" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="1" colspan="1" align="center">SNP</th><th rowspan="1" colspan="1" align="center">Chr</th><th rowspan="1" colspan="1" align="center">bp Position<sup>a</sup></th><th rowspan="1" colspan="1" align="center">Effect<sup>b</sup></th><th rowspan="1" colspan="1" align="center">Lower 95% CI</th><th rowspan="1" colspan="1" align="center">Upper 95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em> Value</th><th rowspan="1" colspan="1" align="center">MAF</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left"><strong>rs1864729</strong></td><td rowspan="1" colspan="1" align="center"><strong>8</strong></td><td rowspan="1" colspan="1" align="center"><strong>98 351 365</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.589</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.350</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.871</strong></td><td rowspan="1" colspan="1" align="center"><strong>3.49E-08</strong></td><td rowspan="1" colspan="1" align="center"><strong>0.098</strong></td></tr><tr><td rowspan="1" colspan="1" align="left"><strong>rs2567769</strong></td><td rowspan="1" colspan="1" align="center"><strong>8</strong></td><td rowspan="1" colspan="1" align="center"><strong>98 367 024</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.581</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.341</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.864</strong></td><td rowspan="1" colspan="1" align="center"><strong>6.49E-08</strong></td><td rowspan="1" colspan="1" align="center"><strong>0.087</strong></td></tr><tr><td rowspan="1" colspan="1" align="left">rs11688246</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">85 559 188</td><td rowspan="1" colspan="1" align="center">1.832</td><td rowspan="1" colspan="1" align="center">1.469</td><td rowspan="1" colspan="1" align="center">2.285</td><td rowspan="1" colspan="1" align="center">1.04E-07</td><td rowspan="1" colspan="1" align="center">0.052</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4902141</td><td rowspan="1" colspan="1" align="center">14</td><td rowspan="1" colspan="1" align="center">62 038 148</td><td rowspan="1" colspan="1" align="center">2.161</td><td rowspan="1" colspan="1" align="center">1.629</td><td rowspan="1" colspan="1" align="center">2.867</td><td rowspan="1" colspan="1" align="center">1.23E-07</td><td rowspan="1" colspan="1" align="center">0.026</td></tr><tr><td rowspan="1" colspan="1" align="left">rs12565140</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">33 701 345</td><td rowspan="1" colspan="1" align="center">1.425</td><td rowspan="1" colspan="1" align="center">1.247</td><td rowspan="1" colspan="1" align="center">1.629</td><td rowspan="1" colspan="1" align="center">2.52E-07</td><td rowspan="1" colspan="1" align="center">0.136</td></tr><tr><td rowspan="1" colspan="1" align="left"><strong>rs2567768</strong></td><td rowspan="1" colspan="1" align="center"><strong>8</strong></td><td rowspan="1" colspan="1" align="center"><strong>98 372 327</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.532</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.305</strong></td><td rowspan="1" colspan="1" align="center"><strong>1.800</strong></td><td rowspan="1" colspan="1" align="center"><strong>2.61E-07</strong></td><td rowspan="1" colspan="1" align="center"><strong>0.098</strong></td></tr><tr><td rowspan="1" colspan="1" align="left">rs12118390</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">80 683 702</td><td rowspan="1" colspan="1" align="center">2.253</td><td rowspan="1" colspan="1" align="center">1.658</td><td rowspan="1" colspan="1" align="center">3.060</td><td rowspan="1" colspan="1" align="center">2.62E-07</td><td rowspan="1" colspan="1" align="center">0.022</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4699587</td><td rowspan="1" colspan="1" align="center">4</td><td rowspan="1" colspan="1" align="center">95 834 792</td><td rowspan="1" colspan="1" align="center">1.763</td><td rowspan="1" colspan="1" align="center">1.416</td><td rowspan="1" colspan="1" align="center">2.194</td><td rowspan="1" colspan="1" align="center">4.79E-07</td><td rowspan="1" colspan="1" align="center">0.048</td></tr><tr><td rowspan="1" colspan="1" align="left">rs16906958</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">80 683 200</td><td rowspan="1" colspan="1" align="center">1.857</td><td rowspan="1" colspan="1" align="center">1.461</td><td rowspan="1" colspan="1" align="center">2.361</td><td rowspan="1" colspan="1" align="center">5.38E-07</td><td rowspan="1" colspan="1" align="center">0.043</td></tr><tr><td rowspan="1" colspan="1" align="left">rs7072122</td><td rowspan="1" colspan="1" align="center">10</td><td rowspan="1" colspan="1" align="center">44 354 678</td><td rowspan="1" colspan="1" align="center">1.730</td><td rowspan="1" colspan="1" align="center">1.397</td><td rowspan="1" colspan="1" align="center">2.141</td><td rowspan="1" colspan="1" align="center">6.03E-07</td><td rowspan="1" colspan="1" align="center">0.051</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4761470</td><td rowspan="1" colspan="1" align="center">12</td><td rowspan="1" colspan="1" align="center">93 207 335</td><td rowspan="1" colspan="1" align="center">1.375</td><td rowspan="1" colspan="1" align="center">1.214</td><td rowspan="1" colspan="1" align="center">1.556</td><td rowspan="1" colspan="1" align="center">6.14E-07</td><td rowspan="1" colspan="1" align="center">0.177</td></tr><tr><td rowspan="1" colspan="1" align="left">rs10515260</td><td rowspan="1" colspan="1" align="center">5</td><td rowspan="1" colspan="1" align="center">97 102 304</td><td rowspan="1" colspan="1" align="center">1.913</td><td rowspan="1" colspan="1" align="center">1.485</td><td rowspan="1" colspan="1" align="center">2.463</td><td rowspan="1" colspan="1" align="center">6.34E-07</td><td rowspan="1" colspan="1" align="center">0.035</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11107531</td><td rowspan="1" colspan="1" align="center">12</td><td rowspan="1" colspan="1" align="center">93 325 452</td><td rowspan="1" colspan="1" align="center">1.328</td><td rowspan="1" colspan="1" align="center">1.187</td><td rowspan="1" colspan="1" align="center">1.485</td><td rowspan="1" colspan="1" align="center">8.31E-07</td><td rowspan="1" colspan="1" align="center">0.243</td></tr><tr><td rowspan="1" colspan="1" align="left">rs17339671</td><td rowspan="1" colspan="1" align="center">4</td><td rowspan="1" colspan="1" align="center">95 832 198</td><td rowspan="1" colspan="1" align="center">1.467</td><td rowspan="1" colspan="1" align="center">1.259</td><td rowspan="1" colspan="1" align="center">1.709</td><td rowspan="1" colspan="1" align="center">1.14E-06</td><td rowspan="1" colspan="1" align="center">0.107</td></tr><tr><td rowspan="1" colspan="1" align="left">rs16832889</td><td rowspan="1" colspan="1" align="center">3</td><td rowspan="1" colspan="1" align="center">183 333 978</td><td rowspan="1" colspan="1" align="center">3.085</td><td rowspan="1" colspan="1" align="center">1.965</td><td rowspan="1" colspan="1" align="center">4.844</td><td rowspan="1" colspan="1" align="center">1.20E-06</td><td rowspan="1" colspan="1" align="center">0.011</td></tr><tr><td rowspan="1" colspan="1" align="left">rs17042688</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">52 365 298</td><td rowspan="1" colspan="1" align="center">1.911</td><td rowspan="1" colspan="1" align="center">1.474</td><td rowspan="1" colspan="1" align="center">2.476</td><td rowspan="1" colspan="1" align="center">1.20E-06</td><td rowspan="1" colspan="1" align="center">0.038</td></tr><tr><td rowspan="1" colspan="1" align="left">rs10501858</td><td rowspan="1" colspan="1" align="center">11</td><td rowspan="1" colspan="1" align="center">125 535 825</td><td rowspan="1" colspan="1" align="center">1.539</td><td rowspan="1" colspan="1" align="center">1.295</td><td rowspan="1" colspan="1" align="center">1.829</td><td rowspan="1" colspan="1" align="center">1.24E-06</td><td rowspan="1" colspan="1" align="center">0.091</td></tr><tr><td rowspan="1" colspan="1" align="left">rs1953248</td><td rowspan="1" colspan="1" align="center">14</td><td rowspan="1" colspan="1" align="center">62 192 760</td><td rowspan="1" colspan="1" align="center">1.613</td><td rowspan="1" colspan="1" align="center">1.331</td><td rowspan="1" colspan="1" align="center">1.953</td><td rowspan="1" colspan="1" align="center">1.25E-06</td><td rowspan="1" colspan="1" align="center">0.073</td></tr><tr><td rowspan="1" colspan="1" align="left">rs12620464</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">101 396 078</td><td rowspan="1" colspan="1" align="center">1.397</td><td rowspan="1" colspan="1" align="center">1.221</td><td rowspan="1" colspan="1" align="center">1.597</td><td rowspan="1" colspan="1" align="center">1.29E-06</td><td rowspan="1" colspan="1" align="center">0.143</td></tr><tr><td rowspan="1" colspan="1" align="left">rs12475021</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">52 388 911</td><td rowspan="1" colspan="1" align="center">1.917</td><td rowspan="1" colspan="1" align="center">1.476</td><td rowspan="1" colspan="1" align="center">2.492</td><td rowspan="1" colspan="1" align="center">1.36E-06</td><td rowspan="1" colspan="1" align="center">0.037</td></tr><tr><td rowspan="1" colspan="1" align="left">rs6077414</td><td rowspan="1" colspan="1" align="center">20</td><td rowspan="1" colspan="1" align="center">8 652 552</td><td rowspan="1" colspan="1" align="center">1.466</td><td rowspan="1" colspan="1" align="center">1.257</td><td rowspan="1" colspan="1" align="center">1.711</td><td rowspan="1" colspan="1" align="center">1.41E-06</td><td rowspan="1" colspan="1" align="center">0.092</td></tr><tr><td rowspan="1" colspan="1" align="left">rs478665</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">65 288 121</td><td rowspan="1" colspan="1" align="center">1.772</td><td rowspan="1" colspan="1" align="center">1.407</td><td rowspan="1" colspan="1" align="center">2.233</td><td rowspan="1" colspan="1" align="center">1.45E-06</td><td rowspan="1" colspan="1" align="center">0.050</td></tr><tr><td rowspan="1" colspan="1" align="left">rs727333</td><td rowspan="1" colspan="1" align="center">21</td><td rowspan="1" colspan="1" align="center">40 624 817</td><td rowspan="1" colspan="1" align="center">1.542</td><td rowspan="1" colspan="1" align="center">1.295</td><td rowspan="1" colspan="1" align="center">1.837</td><td rowspan="1" colspan="1" align="center">1.47E-06</td><td rowspan="1" colspan="1" align="center">0.081</td></tr><tr><td rowspan="1" colspan="1" align="left">rs724767</td><td rowspan="1" colspan="1" align="center">3</td><td rowspan="1" colspan="1" align="center">195 205 024</td><td rowspan="1" colspan="1" align="center">1.436</td><td rowspan="1" colspan="1" align="center">1.241</td><td rowspan="1" colspan="1" align="center">1.663</td><td rowspan="1" colspan="1" align="center">1.52E-06</td><td rowspan="1" colspan="1" align="center">0.115</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11548323</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">27 604 238</td><td rowspan="1" colspan="1" align="center">1.396</td><td rowspan="1" colspan="1" align="center">1.219</td><td rowspan="1" colspan="1" align="center">1.598</td><td rowspan="1" colspan="1" align="center">1.70E-06</td><td rowspan="1" colspan="1" align="center">0.170</td></tr></tbody></table></div><div id="largeobj_idm140707388541504" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3607698/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140707392903392"><p id="__p27" class="p p-first-last">Bold face, are the three SNPs in or near the <em>TSPYL5</em> gene.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3.</h3><!--caption a7--><div class="caption"><p id="__p28">Imputed (I) and subsequently genotyped chromosome 8 SNPs surrounding <em>TSPYL5</em> (all with <em>P</em> &lt; 5E-08). O, observed during GWAS genotyping</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707391344192" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="1" colspan="1" align="center">SNP</th><th rowspan="1" colspan="1" align="center">Chr</th><th rowspan="1" colspan="1" align="center">bp Position<sup>a</sup></th><th rowspan="1" colspan="1" align="center">Effect<sup>b</sup></th><th rowspan="1" colspan="1" align="center">Lower 95% CI</th><th rowspan="1" colspan="1" align="center">Upper 95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em> Value</th><th rowspan="1" colspan="1" align="center">MAF</th><th rowspan="1" colspan="1" align="center">Imputed (I) or Observed (O)</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">rs2451114</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98273762</td><td rowspan="1" colspan="1" align="center">1.64441</td><td rowspan="1" colspan="1" align="center">1.402311</td><td rowspan="1" colspan="1" align="center">1.928305</td><td rowspan="1" colspan="1" align="center">1.50E-09</td><td rowspan="1" colspan="1" align="center">0.100361</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2451113</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98273448</td><td rowspan="1" colspan="1" align="center">1.63402</td><td rowspan="1" colspan="1" align="center">1.389243</td><td rowspan="1" colspan="1" align="center">1.921925</td><td rowspan="1" colspan="1" align="center">4.62E-09</td><td rowspan="1" colspan="1" align="center">0.093637</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2439702</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98272647</td><td rowspan="1" colspan="1" align="center">1.631933</td><td rowspan="1" colspan="1" align="center">1.385699</td><td rowspan="1" colspan="1" align="center">1.921922</td><td rowspan="1" colspan="1" align="center">6.60E-09</td><td rowspan="1" colspan="1" align="center">0.093863</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2053480</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98278951</td><td rowspan="1" colspan="1" align="center">1.627991</td><td rowspan="1" colspan="1" align="center">1.383235</td><td rowspan="1" colspan="1" align="center">1.916056</td><td rowspan="1" colspan="1" align="center">6.84E-09</td><td rowspan="1" colspan="1" align="center">0.093149</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2567773</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98279182</td><td rowspan="1" colspan="1" align="center">1.627991</td><td rowspan="1" colspan="1" align="center">1.383235</td><td rowspan="1" colspan="1" align="center">1.916056</td><td rowspan="1" colspan="1" align="center">6.84E-09</td><td rowspan="1" colspan="1" align="center">0.092659</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2853312</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98281319</td><td rowspan="1" colspan="1" align="center">1.619799</td><td rowspan="1" colspan="1" align="center">1.377337</td><td rowspan="1" colspan="1" align="center">1.904943</td><td rowspan="1" colspan="1" align="center">8.27E-09</td><td rowspan="1" colspan="1" align="center">0.094952</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2635162</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98283629</td><td rowspan="1" colspan="1" align="center">1.621225</td><td rowspan="1" colspan="1" align="center">1.374058</td><td rowspan="1" colspan="1" align="center">1.912853</td><td rowspan="1" colspan="1" align="center">1.50E-08</td><td rowspan="1" colspan="1" align="center">0.098439</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2583506</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98281847</td><td rowspan="1" colspan="1" align="center">1.614156</td><td rowspan="1" colspan="1" align="center">1.369888</td><td rowspan="1" colspan="1" align="center">1.90198</td><td rowspan="1" colspan="1" align="center">1.55E-08</td><td rowspan="1" colspan="1" align="center">0.101205</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs1348184</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98276912</td><td rowspan="1" colspan="1" align="center">1.615936</td><td rowspan="1" colspan="1" align="center">1.37075</td><td rowspan="1" colspan="1" align="center">1.90498</td><td rowspan="1" colspan="1" align="center">1.58E-08</td><td rowspan="1" colspan="1" align="center">0.098558</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2053481</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98278923</td><td rowspan="1" colspan="1" align="center">1.615936</td><td rowspan="1" colspan="1" align="center">1.37075</td><td rowspan="1" colspan="1" align="center">1.90498</td><td rowspan="1" colspan="1" align="center">1.58E-08</td><td rowspan="1" colspan="1" align="center">0.098439</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2439700</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98277168</td><td rowspan="1" colspan="1" align="center">1.615936</td><td rowspan="1" colspan="1" align="center">1.37075</td><td rowspan="1" colspan="1" align="center">1.90498</td><td rowspan="1" colspan="1" align="center">1.58E-08</td><td rowspan="1" colspan="1" align="center">0.098193</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2853318</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98283509</td><td rowspan="1" colspan="1" align="center">1.611976</td><td rowspan="1" colspan="1" align="center">1.367697</td><td rowspan="1" colspan="1" align="center">1.899885</td><td rowspan="1" colspan="1" align="center">1.78E-08</td><td rowspan="1" colspan="1" align="center">0.097839</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2853320</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98283523</td><td rowspan="1" colspan="1" align="center">1.611976</td><td rowspan="1" colspan="1" align="center">1.367697</td><td rowspan="1" colspan="1" align="center">1.899885</td><td rowspan="1" colspan="1" align="center">1.78E-08</td><td rowspan="1" colspan="1" align="center">0.097839</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2583504</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98283404</td><td rowspan="1" colspan="1" align="center">1.612618</td><td rowspan="1" colspan="1" align="center">1.367138</td><td rowspan="1" colspan="1" align="center">1.902177</td><td rowspan="1" colspan="1" align="center">2.03E-08</td><td rowspan="1" colspan="1" align="center">0.098676</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs1431891</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98282716</td><td rowspan="1" colspan="1" align="center">1.606092</td><td rowspan="1" colspan="1" align="center">1.362664</td><td rowspan="1" colspan="1" align="center">1.893006</td><td rowspan="1" colspan="1" align="center">2.29E-08</td><td rowspan="1" colspan="1" align="center">0.099159</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs1835743</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98282643</td><td rowspan="1" colspan="1" align="center">1.606092</td><td rowspan="1" colspan="1" align="center">1.362664</td><td rowspan="1" colspan="1" align="center">1.893006</td><td rowspan="1" colspan="1" align="center">2.29E-08</td><td rowspan="1" colspan="1" align="center">0.09904</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2635161</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98282907</td><td rowspan="1" colspan="1" align="center">1.606092</td><td rowspan="1" colspan="1" align="center">1.362664</td><td rowspan="1" colspan="1" align="center">1.893006</td><td rowspan="1" colspan="1" align="center">2.29E-08</td><td rowspan="1" colspan="1" align="center">0.098676</td><td rowspan="1" colspan="1" align="left">I</td></tr><tr><td rowspan="1" colspan="1" align="left">rs1864729</td><td rowspan="1" colspan="1" align="center">8</td><td rowspan="1" colspan="1" align="center">98282189</td><td rowspan="1" colspan="1" align="center">1.589376</td><td rowspan="1" colspan="1" align="center">1.350376</td><td rowspan="1" colspan="1" align="center">1.870676</td><td rowspan="1" colspan="1" align="center">3.49E-08</td><td rowspan="1" colspan="1" align="center">0.09807</td><td rowspan="1" colspan="1" align="left">O</td></tr></tbody></table></div><div id="largeobj_idm140707391344192" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3607698/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF3-1"><sup>a</sup> Genome Build 37.</div><div id="TF3-2"><sup>b</sup> Multiplicative effect from quasi-likelihood model.</div></div></div></div><div id="__sec15" class="sec"><h3 id="__sec15title">Plasma E2 concentrations</h3><p id="__p31" class="p p-first">Plasma E2 concentrations in patients enrolled in this study displayed substantial individual variation (mean = 5.6 pg/mL, SD = 6.9, median = 4.0, 25<sup>th</sup> percentile = 2.5, 75<sup>th</sup> percentile = 6.6, max = 111.0). Plasma E2 concentrations in patients homozygous for the variant rs1864729 SNP observed during GWAS genotyping had average plasma E2 concentrations more than 2-fold higher (11.15 pg/mL) than those in subjects homozygous for the wild-type (WT) allele (5.00 pg/mL) (<a href="/pmc/articles/PMC3607698/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>A). Even though plasma E2 concentrations for some of the patients were more than 10 pg/mL, all of these women had been considered clinically postmenopausal by their referring oncologist. BMI values for these women also varied greatly, ranging from 16.0 to 57.2, with mean and SD values of 27.9 and 6.20, respectively. The median age at the time of enrollment in the study was 66.8 years, with a range from 39.1 to 95.4 years. 40.3% of patients had received prior chemotherapy, whereas 10.6% had prior tamoxifen treatment. In a previous preliminary study of E2 concentrations in the initial 200 patients enrolled in this study, we reported that two SNPs in the <em>CYP19A1</em> “placental promoter”, I.1, were associated with elevated plasma E2 concentrations (<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775167">8</a>). When we genotyped those SNPs and examined their association with plasma E2 concentration in the present group of 772 women, we confirmed a strong association between these two SNPs and plasma E2 concentrations (<em>P</em> values of 1E-04 for rs6493497 and 5.69E-05 for rs7176605).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3607698/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707393409904" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770002.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770002.jpg" src="/pmc/articles/PMC3607698/bin/zmg0041351770002.jpg"></div></a><div id="largeobj_idm140707393409904" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3607698/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a target="object" href="/pmc/articles/PMC3607698/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3607698/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2.</a></div><!--caption a7--><div class="caption"><p id="__p32">A, Box Plots Of Log Plasma E2 Concentrations Expressed as Picograms per mL by rs1864729 SNP Genotype. The horizontal lines within each box show median values, whereas the red points are mean values for homozygous wild type (Wt/Wt), heterozygous (Wt/V), and homozygous variant SNP (V/V) SNP genotypes. Extreme values are also shown. The number of subjects in the study with each genotype is also listed. B, ChIP assay using ERα stably transfected LCLs with known genotypes for the rs2583506 SNP. Lanes 1–4 and 8–11 are PCR products for DNA that was immunoprecipitated with human ERα antibody. The “input” material for the variant and WT heterozygous (Wt/V) and WT homozygous (Wt/Wt) samples were PCR amplification products from pools of sheared DNA for the entire genome. Lanes 1–6 are ChIP assays for one Wt/Wt and Wt/V LCL pair, and lanes 8–13 are ChIP assays for another pair of LCLs. Lanes 7 and 14 are Invitrogen (Carlsbad, CA) 1-kb DNA ladders.</p></div></div></div></div><div id="__sec16" class="sec"><h3 id="__sec16title"><em>TSPYL5</em> SNPs and function</h3><p id="__p33" class="p p-first-last">We next asked whether any of the chromosome 8 SNPs with <em>P</em> values &lt; 5E-08 might create or disrupt a DNA sequence motif that might participate in the regulation of transcription. The TRANSFAC database predicted that the variant allele for the rs2583506 SNP (see <a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>B) created an estrogen response element (ERE). To test that possibility experimentally, we performed a ChIP assay with two sets of LCLs stably transfected with ERα that were either homozygous for the WT allele or were heterozygous for rs2583506. Because of the low MAF of rs2583506 (0.10), even though we had 40 LCLs that were stably transfected with ERα, we had no cell lines that were homozygous for the variant allele. ChIP assay after incubation with E2 showed that DNA surrounding the rs2583506 SNP that was isolated from LCLs with heterozygous genotypes did bind ERα, but DNA from homozygous WT LCLs did not (<a href="/pmc/articles/PMC3607698/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>B), thus functionally confirming the database prediction and demonstrating that the rs2583506 SNP created a functional ERE.</p></div><div id="__sec17" class="sec"><h3 id="__sec17title">TSPYL5 and CYP19A1 expression</h3><p id="__p34" class="p p-first">Because the SNPs in <em>TSPYL5</em> that are shown graphically in <a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>B had been identified on the basis of their association with plasma E2 concentrations, we next determined whether TSPYL5 might influence the expression of <em>CYP19A1</em>, the gene encoding the cytochrome P450 isoform that catalyzes estradiol synthesis, ie, “aromatase” (<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775165">26</a>). Specifically, we performed qRT-PCR for both TSPYL5 and CYP19A1 mRNA expression after either knocking down TSPYL5 mRNA expression using siRNA, or overexpressing TSPYL5 in three different types of cells, beginning with MCF-7 cells because all of our patients suffered from breast cancer. Because <em>CYP19A1</em> has 10 different promoters that drive expression in a tissue-specific fashion (<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775154">27</a>) (<a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>A), we performed qRT-PCR for all 10 upstream exons that encode 5′-UTR sequences for this gene. It should be emphasized that the tissue specificities listed in the diagram in <a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>A are only generalizations, and many of these promoters are active in several different tissues. Specifically, we used separate primers for each of the 5′-UTR sequences (see <a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>A), in each case paired with a single 3′-primer that hybridized within the open reading frame of the <em>CYP19A1</em> gene (see Supplemental Table 1 for primer sequences). The goal of these experiments was to assay CYP19A1 mRNA expression that was driven by different promoters. In the MCF-7 cells, only the I.4 promoter that primarily drives aromatase expression in adipose tissue and skin was detected. That observation was of interest because most circulating E2 in postmenopausal women originates from adipose tissue (<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775144">28</a>), another cell type that we studied, as described in subsequent paragraphs. When <em>TSPYL5</em> was overexpressed 48-fold in MCF-7 cells as determined by qRT-PCR, expression of the <em>CYP19A1</em> I.4 promoter increased approximately 4-fold (<a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>B, left panel). Obviously, data obtained using overexpression must always be interpreted with caution. Therefore, we also tested the effect of TSPYL5 knockdown. When <em>TSPYL5</em> was knocked down to 24% of baseline by using a siRNA pool, expression of the I.4 <em>CYP19A1</em> promoter was decreased to 50% of the basal value (<a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>B, right panel). Western blot analyses showed that protein levels for both TSPYL5 and CYP19A1 in MCF-7 cells (<a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>C) paralleled the results of assays of mRNA expression (<a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>B). It should be pointed out that basal levels of CYP19A1 mRNA expression in the MCF-7 cells were relatively low, as reported previously by Zhou, Pampon, and Shen in 1990 (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775151">29</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707384548864" class="figure"><a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3607698_zmg0041351770003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3607698/bin/zmg0041351770003.jpg"></a></div><div id="largeobj_idm140707384548864" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3607698/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3607698/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3.</a></div><!--caption a7--><div class="caption"><p id="__p35">A, Schematic diagrams of promoters for the <em>CYP19A1</em> gene. The relative tissue specificity for each promoter is listed. The skin/adipose I.4 promoter is highlighted in red. B, TSPYL5 and CYP19A1 skin/adipose tissue promoter mRNA expression levels after TSPYL5 overexpression (OE) and knockdown (KD) in MCF-7 cells. *. <em>P</em> &lt; .05; **, <em>P</em> &lt; .01; and ***, <em>P</em> &lt; .001 when compared with baseline. C, Western blot analyses of TSPYL5 and CYP19A1 protein levels after TSPYL5 was knocked down (KD) or overexpressed (OE) in MCF-7 cells. CON, control.</p></div></div></div><p id="__p36">Having demonstrated that TSPYL5 expression was associated with the expression of CYP19A1 in MCF-7 cells, we next wanted to determine the possible effect of different <em>TSPYL5</em> SNP genotypes on the expression of the <em>TSPYL5</em> gene and whether exposure to estrogens might influence TSPYL5 expression because one of the variant SNPs, rs2583506, created a functional ERE. We then wanted to determine the possible relationship of TSPYL5 SNP-dependent expression with the expression of <em>CYP19A1</em>. As mentioned previously, we had stably transfected a series of Human Variation Panel LCLs with known genotypes for rs1864729, rs2567769, and rs2583506 with ERα. We should emphasize once again the importance of the availability of this genomic data-rich human cell line model system for testing the relationship of variant genotypes to biochemical phenotypes. Specifically, we exposed three LCLs that were homozygous WT for these SNPs and three LCLs that were heterozygous to increasing concentrations of E2 for 24 hours. Cell lines with heterozygous genotypes, ie, those that included the functional ERE created by the rs2583506 SNP variant allele, showed significantly greater E2 dose-dependent <em>TSPYL5</em> induction after exposure to increasing concentrations of E2 than did homozygous WT LCLs (<a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>, upper left). Of equal interest, transcripts encoded by three different <em>CYP19A1</em> promoters (see <a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>A) were also induced in parallel with the TSPYL5 induction and also showed greater induction in cell lines that carried the rs2583506 variant genotype and, as a result, that had an additional functional ERE near the <em>TSPYL5</em> gene. Specifically, the I.4 skin/adipose promoter (<a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>, upper right), the I.3 adipose tissue/breast cancer promoter (<a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>, lower left), and the I.1 placenta promoter of <em>CYP19A1</em> (<a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>, lower right) were all significantly induced after E2 exposure of LCLs heterozygous for variant <em>TSPYL5</em> rs2583506 genotypes, but not in cell lines homozygous for the WT allele. These results suggested that TSPYL5, either directly or indirectly, increased the expression of CYP19A1. Because most estrogen in postmenopausal women is derived from adipose tissue, the next series of experiments was designed to test the possible relationship of TSPYL5 expression to that of CYP19A1 in human adipocytes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707389556032" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770004.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770004.jpg" src="/pmc/articles/PMC3607698/bin/zmg0041351770004.jpg"></div></a><div id="largeobj_idm140707389556032" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a target="object" href="/pmc/articles/PMC3607698/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC3607698/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4.</a></div><!--caption a7--><div class="caption"><p id="__p37">SNP-Dependent Differences in TSPYL5 Expression in Response to Increasing Concentrations of E2 for Three LCLs Heterozygous (Wt/V, blue lines) for <em>TSPYL5</em> SNPs, and Three LCLs Homozygous for Wt SNP Alleles (Wt/Wt, red lines). All LCLs were stably transfected with ERα. The upper left panel shows relative TSPYL5 mRNA expression, the upper right panel shows relative mRNA expression level for CYP19A1 due to the skin/adipose promoter, the lower left panel shows relative mRNA expression level for CYP19A1 due to the adipose/breast cancer promoter, and the lower right panel shows relative mRNA expression level for CYP19A1 due to the placental promoter. *. <em>P</em> &lt; .05; **, <em>P</em> &lt; .01 when compared with the alternative genotype at the same E2 concentration.</p></div></div></div><p id="__p38" class="p">Specifically, we both knocked down and overexpressed TSPYL5 in HO3sD-96Wa human adipocytes in experiments similar to those performed with MCF-7 cells that are shown graphically in <a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>, B and C. Because the LCL studies had shown a <em>TSPYL5</em> SNP-dependent difference in the expression of CYP19A1 that was driven by the I.4 (skin adipose), I.3 (breast cancer-adipose), and I.1 (placenta) promoters, we tested in adipocytes the expression of CYP19A1 mRNA that was driven by all three of those promoters. As shown in <a href="/pmc/articles/PMC3607698/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>A, overexpression of TSPYL5 resulted in significant increases in CYP19A1 expression associated with all three promoters, whereas knockdown resulted in significant decreases for all except the I.1 promoter. Just as in the case of the MCF-7 cells (<a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>C), Western blot analyses confirmed the qRT-PCR results (<a href="/pmc/articles/PMC3607698/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>B). The next series of experiments was performed to test the hypothesis that TSPYL5 might bind DNA sequences in the <em>CYP191A</em> I.4 promoter.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC3607698/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707392082544" class="figure"><a href="/pmc/articles/PMC3607698/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3607698_zmg0041351770005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3607698/bin/zmg0041351770005.jpg"></a></div><div id="largeobj_idm140707392082544" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3607698/figure/F5/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC3607698/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5.</a></div><!--caption a7--><div class="caption"><p id="__p39">A, TSPYL5 and CYP19A1 mRNA expression levels after TSPYL5 overexpression (OE) (red bars) and knockdown (KD) (blue bars) in HO3sD-96Wa human adipocytes. B, Western blot analysis of TSPYL5 and CYP19A1 protein levels after TSPYL5 OE or KD in HO3sD-96Wa human adipocytes. *, <em>P</em> &lt; .05; **, <em>P</em> &lt; .01. Neg, negative.</p></div></div></div></div><div id="__sec18" class="sec sec-last"><h3 id="__sec18title">TSPYL5 binds to the <em>CYP19A1</em> I.4 promoter</h3><p id="__p40" class="p p-first">We had demonstrated that TSPYL5 appeared to influence <em>CYP19A1</em> expression in MCF-7 cells, LCLs, and adipocytes by acting through the <em>CYP19A1</em> I.4 promoter (<a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>, B and C, <a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>, and <a href="/pmc/articles/PMC3607698/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>A). To determine whether TSPYL5 might be capable of binding directly to the <em>CYP19A1</em> I.4 promoter, we designed a series of qPCR primers to amplify overlapping sequences (50–90 bp in length) across the length of the I.4 promoter and used ChIP assays to determine whether any portion of the promoter might include DNA sequence motifs to which TSPYL5 might bind. Both qPCR and DNA-agarose gel-based ChIP assays performed with TSPYL5 antibody indicated that an approximately 120-bp region of DNA in the I.4 promoter, a region that was amplified by the F2R3 and F2R5 primer pairs, appeared to bind TSPYL5 (<a href="/pmc/articles/PMC3607698/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>). The sequence of the approximately 120-bp DNA region to which TSPYL5 bound in the <em>CYP19A1</em> skin/adipose I.4 promoter was 5′-GCCCTCTGGAATCTGTGAAATCTAGAAACTAGATTGGGAAAA CTCTGACACCCCTGCCCCATGACCAACCAAGACTAAGAGTCCCAGGAAGATTGAGGTCACAGAAGGCAGAGGCCTG-3′. We then performed a BLAST (Basic Local Alignment Search Tool) homology search across the genome with this 120-bp sequence and identified a large number of genes that contained a portion of the 120-bp region, either within the gene or up to 1000 bp 5′- of the gene. We next aligned all of those sequences and identified a 5′-TCANNGAAGGCAG-3′ motif that was present in 43 of the genes that we had identified during the BLAST search. Those 43 genes are listed in <a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC3607698/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707393210528" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770006.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770006.jpg" src="/pmc/articles/PMC3607698/bin/zmg0041351770006.jpg"></div></a><div id="largeobj_idm140707393210528" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3607698/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"></a><a target="object" href="/pmc/articles/PMC3607698/figure/F6/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC3607698/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6.</a></div><!--caption a7--><div class="caption"><p id="__p41">ChIP Assays in MCF-7 Cells Using TSPYL5 Antibody. A, The upper panel shows PCR amplification after ChIP assay using different primer pairs within the skin/adipose promoter region of the <em>CYP19A1</em> gene in MCF-7 cells. B, The lower panel shows qPCR quantification of the same ChIP assay shown in panel A. Ab, Antibody; w/o, without.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>Table 4.</h3><!--caption a7--><div class="caption"><p id="__p42">(A) Forty-three genes containing a putative <em>TSPYL5</em> DNA binding motif 5′-TCANNGAAGGCAG-3′. (B) The 21 genes containing this motif 5′ to the site of transcription initiation with expression that correlated with TSPYL5 expression in at least 2 cell lines. (C) The 7 genes containing this motif 5′ to the site of transcription initiation with expression that was correlated with TSPYL5 expression in all 3 cell lines tested</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707386646720" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">A. Genes with the putative binding motif</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    CAST</td><td rowspan="1" colspan="1" align="left">CRYBA4</td><td rowspan="1" colspan="1" align="left">DCLK2</td><td rowspan="1" colspan="1" align="left">MRPL39</td></tr><tr><td rowspan="1" colspan="1" align="left">    TASP1</td><td rowspan="1" colspan="1" align="left">MN1</td><td rowspan="1" colspan="1" align="left">SPATA16</td><td rowspan="1" colspan="1" align="left">PLCL1</td></tr><tr><td rowspan="1" colspan="1" align="left">    FBXW7</td><td rowspan="1" colspan="1" align="left">SEC14L3</td><td rowspan="1" colspan="1" align="left">NLGN1</td><td rowspan="1" colspan="1" align="left">GABRD</td></tr><tr><td rowspan="1" colspan="1" align="left">    AZIN1</td><td rowspan="1" colspan="1" align="left">SEC14L4</td><td rowspan="1" colspan="1" align="left">CYP11B1</td><td rowspan="1" colspan="1" align="left">NRXN1</td></tr><tr><td rowspan="1" colspan="1" align="left">    FBXW72</td><td rowspan="1" colspan="1" align="left">CNTNAP2</td><td rowspan="1" colspan="1" align="left">NCAM2</td><td rowspan="1" colspan="1" align="left">NR3C1</td></tr><tr><td rowspan="1" colspan="1" align="left">    CAST</td><td rowspan="1" colspan="1" align="left">DTD1</td><td rowspan="1" colspan="1" align="left">MRPS30</td><td rowspan="1" colspan="1" align="left">RWDD3</td></tr><tr><td rowspan="1" colspan="1" align="left">    ATP13A5</td><td rowspan="1" colspan="1" align="left">ASB3</td><td rowspan="1" colspan="1" align="left">ESF1</td><td rowspan="1" colspan="1" align="left">F11R</td></tr><tr><td rowspan="1" colspan="1" align="left">    GPHN</td><td rowspan="1" colspan="1" align="left">PTBP2</td><td rowspan="1" colspan="1" align="left">CYP19A</td><td rowspan="1" colspan="1" align="left">FUT8</td></tr><tr><td rowspan="1" colspan="1" align="left">    CRYBA4</td><td rowspan="1" colspan="1" align="left">DCLK2</td><td rowspan="1" colspan="1" align="left">XRXN1</td><td rowspan="1" colspan="1" align="left">GLDN</td></tr><tr><td rowspan="1" colspan="1" align="left">    SEC14L3</td><td rowspan="1" colspan="1" align="left">CNTNAP2</td><td rowspan="1" colspan="1" align="left">PET112L</td><td rowspan="1" colspan="1" align="left">HDAC4</td></tr><tr><td rowspan="1" colspan="1" align="left">    USP24</td><td rowspan="1" colspan="1" align="left">WRXN</td><td rowspan="1" colspan="1" align="left">DYDC1</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">B. Genes with the putative binding motif and expression that correlated with TSPYL5 expression in two of the cell lines tested</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    FBXW7</td><td rowspan="1" colspan="1" align="left">CAST</td><td rowspan="1" colspan="1" align="left">F11R</td><td rowspan="1" colspan="1" align="left">PTBP2</td></tr><tr><td rowspan="1" colspan="1" align="left">    FUT8</td><td rowspan="1" colspan="1" align="left">ASB3</td><td rowspan="1" colspan="1" align="left">MN1</td><td rowspan="1" colspan="1" align="left">DCLK2</td></tr><tr><td rowspan="1" colspan="1" align="left">    SPATA16</td><td rowspan="1" colspan="1" align="left">GABRD</td><td rowspan="1" colspan="1" align="left">ESF1</td><td rowspan="1" colspan="1" align="left">PET112L</td></tr><tr><td rowspan="1" colspan="1" align="left">    TASP</td><td rowspan="1" colspan="1" align="left">HDAC4</td><td rowspan="1" colspan="1" align="left">USP24</td><td rowspan="1" colspan="1" align="left">MRPL39</td></tr><tr><td rowspan="1" colspan="1" align="left">    GDHN</td><td rowspan="1" colspan="1" align="left">NCAM2</td><td rowspan="1" colspan="1" align="left">MRPS30</td><td rowspan="1" colspan="1" align="left">AZIN1</td></tr><tr><td rowspan="1" colspan="1" align="left">    DCLK2</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">C. Genes with the putative binding motif and expression that correlated with TSPYL5 expression in all three cell lines tested</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    FBXW7</td><td rowspan="1" colspan="1" align="left">CAST</td><td rowspan="1" colspan="1" align="left">F11R</td><td rowspan="1" colspan="1" align="left">PRBP2</td></tr><tr><td rowspan="1" colspan="1" align="left">    FUT8</td><td rowspan="1" colspan="1" align="left">ASB3</td><td rowspan="1" colspan="1" align="left">MN1</td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140707386646720" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3607698/table/T4/?report=objectonly">Open in a separate window</a></div></div><p id="__p43">The next step involved an attempt to determine whether TSPYL5 might regulate the expression of the genes listed in <a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>. To do that, we both knocked down <em>TSPYL5</em> mRNA expression with a siRNA pool and overexpressed <em>TSPYL5</em> in MCF-7, IMR-90, and HEK293T cells, all of which display high basal expression of TSPYL5 mRNA. That made it possible to use qRT-PCR to test the effect of TSPYL5 knockdown or overexpression on expression levels of the genes listed in <a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>A. After the removal of 16 genes that were not expressed in all three of the cell lines, we found that when TSPYL5 was knocked down to less than 7% of baseline in MCF-7 cells, the expression of 26 of the 27 genes of interest expressed in that cell line also decreased (<a href="/pmc/articles/PMC3607698/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>A, blue bars). Conversely, when <em>TSPYL5</em> was overexpressed 5.7-fold, the expression of 16 of the 27 genes increased (<a href="/pmc/articles/PMC3607698/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>A, red bars). In a similar fashion, after TSPYL5 was knocked down to 5% of the basal level in IMR-90 cells, the expression of 24 of 25 genes expressed in that cell line also decreased, and when TSPYL5 was overexpressed 347-fold, the expression of 9 of the 25 expressed genes increased (<a href="/pmc/articles/PMC3607698/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>B). In HEK293T cells, when TSPYL5 expression was knocked down to 19% of baseline, the expression of 24 of the 27 genes listed in <a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>A expressed in that cell line decreased and, when TSPYL5 was overexpressed 7843-fold, the expression of 22 of the 27 genes increased (<a href="/pmc/articles/PMC3607698/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figure 7</span></a>C).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC3607698/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707427642048" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770007.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770007.jpg" src="/pmc/articles/PMC3607698/bin/zmg0041351770007.jpg"></div></a><div id="largeobj_idm140707427642048" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3607698/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"></a><a target="object" href="/pmc/articles/PMC3607698/figure/F7/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC3607698/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Figure 7.</a></div><!--caption a7--><div class="caption"><p id="__p44">Effect of TSPYL5A Overexpression (OE) and Knockdown (KD)on the Relative mRNA Expression of Genes That Contain the Putative TSPYL5 DNA Binding Motif in (A) MCF-7, (B) IMR-90, and (C) HEK293T Cells. Red bars represent data for TSPYL5 overexpression and blue bars represent data for TSPYL5 knockdown. The blue dash lines represent control levels of expression.</p></div></div></div><p id="__p45" class="p">When we combined the results for all three cell lines, we found that seven of the 45 genes showed the same directional expression changes in all three cell lines (<a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>C), and 21 of the 45 genes showed the same pattern of regulation in at least two of the three cell lines (<a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>B). Finally, to determine whether TSPYL5 might physically bind to the hypothetical “TSPYL5” binding motifs present in these genes, we performed ChIP assays in MCF-7 cells using TSPYL5 antibody and detected binding to the area surrounding the predicted motif by using primers designed to detect TSPYL5 binding to or near the target sequence motif. The sequences of the primers used to perform these ChIP assays are listed in Supplemental Table 2. In some genes there was more than one of these putative TSPYL5 DNA binding motifs, so we performed ChIP assays to test all of the potential TSPYL5 binding sites (<a href="/pmc/articles/PMC3607698/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span>Figure 8</span></a>). We found that 21 of the 43 genes listed in <a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>A displayed TSPYL5 binding to or near the sequence motif that we had identified during our BLAST analyses (<a href="/pmc/articles/PMC3607698/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span>Figure 8</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F8" co-legend-rid="lgnd_F8"><a href="/pmc/articles/PMC3607698/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140707427632784" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770008.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zmg0041351770008.jpg" src="/pmc/articles/PMC3607698/bin/zmg0041351770008.jpg"></div></a><div id="largeobj_idm140707427632784" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3607698/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8"></a><a target="object" href="/pmc/articles/PMC3607698/figure/F8/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F8"><div><a class="figpopup" href="/pmc/articles/PMC3607698/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8">Figure 8.</a></div><!--caption a7--><div class="caption"><p id="__p46">ChIP Assays That Demonstrate the Binding of TSPYL5 to Areas of Genes That Contained the Putative TSPYL5 DNA Binding Motif. ChIP was performed in MCF-7 cells with anti-TSPYL5 antibody. In each case the top panel shows the results of qRT-PCR demonstrating the relative enrichment of TSPYL5 DNA motif sequences after immunoprecipitation with anti-TSPYL5 antibody (blue) as compared with no antibody (IgG only) (orange). Sequences of primers utilized to perform these assays are listed in Supplemental Table 2. At the bottom of each figure are ChIP results after PCR amplification shown relative to input on a 1.0% agarose gel. Some genes contained more than one TSPYL5 DNA binding motif, so they were labeled as “-1”, “-2”, “-3” etc.</p></div></div></div></div></div><div id="__sec19" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec19title">Discussion</h2><p id="__p47" class="p p-first">Plasma E2 concentrations decrease approximately 50-fold after menopause, but these decreased levels of E2 continue to show large individual variation (<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775163">30</a>). That variation may play a role in disease pathophysiology or risk (<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775139">31</a>). Therefore, we performed a discovery GWAS in an attempt to identify novel genetic factors that might play a role in variation in postmenopausal plasma E2 concentrations. It should be emphasized that all of our subjects were women with early stage ER(+) breast cancer who were candidates for 5 years of aromatase inhibitor therapy to help prevent recurrence. Therefore, we are unable to conclude that our observations would also apply to women who do not suffer from breast cancer. In future studies, the possible contribution of <em>TSPYL5</em> SNPs to variation in plasma E2 concentrations in women without breast cancer will have to be determined. Because our study was designed to test the hypothesis that inheritance might alter response to aromatase inhibitors, and because aromatase inhibitor therapy lowers the already low postmenopausal E2 concentrations studied here, we used a sensitive GC-MS/MS method to assay plasma E2 levels. We observed a series of genome-wide significant SNPs in and near the <em>TSPYL5</em> gene that were associated with plasma E2 concentrations in these patients (<a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>, A and B).</p><p id="__p48">The most significant of the <em>TSPYL5</em> SNPs on the GWAS genotyping platform had association <em>P</em> values of less than 5E-08, <em>ie</em>., it was genome-wide significant (<a href="/pmc/articles/PMC3607698/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>B). Furthermore, one of the imputed SNPs, rs2583506, created a functional ERE based on the results of ChIP assay (<a href="/pmc/articles/PMC3607698/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>B), and the expression of <em>TSPYL5</em> in LCLs heterozygous for the variant allele showed E2-dependent induction of TSPYL5 mRNA expression, whereas little change was seen in cell lines homozygous for the WT allele (<a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>)—all observations compatible with the creation of a functional ERE by the variant allele. These observations represent the first demonstration of a relationship between circulating E2 concentrations and the expression of <em>TSPYL5</em>. That could be important because circulating estrogen concentrations represent a risk factor for breast cancer (<a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775140">32</a>) and because TSPYL5 expression has been reported to be associated with increased risk for breast cancer (<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775147">9</a>). Therefore, the observations included in the present report may help to explain why TSPYL5 is a risk factor for poor outcomes in patients with breast cancer. Because plasma E2 in postmenopausal women is derived mainly from adipose tissue, it is also relevant that we found that expression driven by the skin/adipose I.4 <em>CYP19A1</em> promoter was correlated with <em>TSPYL5</em> expression in MCF-7 cells, with increased <em>CYP19A1</em> expression both at the RNA and protein levels (<a href="/pmc/articles/PMC3607698/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>, B and C). Furthermore, in LCLs with known genotypes for the <em>TSPYL5</em> SNPs, expression of <em>TSPYL5</em> paralleled not only that of the <em>CYP19A1</em> I.4 (skin/adipose), but also the I.3 (adipose/breast cancer) and I.1 (placenta) promoters after exposure to increasing concentrations of E2 (<a href="/pmc/articles/PMC3607698/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>). These same three <em>CYP19A1</em> promoters also appeared to be associated with the TSPYL5-dependent induction of aromatase mRNA and protein in human adipocytes (<a href="/pmc/articles/PMC3607698/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>). The present results also supported our earlier report based on DNA samples from the initial 200 participants in this study that two SNPs in the <em>CYP19A1</em> I.1 promoter were associated with increased aromatase activity and increased plasma E2 concentration (<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_303775172">8</a>). Finally, we demonstrated that TSPYL5 bound directly to the I.4 skin/adipose promoter of <em>CYP19A1</em>, as shown by ChIP assay (<a href="/pmc/articles/PMC3607698/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>), as well to a putative TSPYL5 binding motif in a number of other genes with mRNA expression that was influenced by TSPYL5 overexpression or knockdown (<a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a> and <a href="/pmc/articles/PMC3607698/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Figures 7</span></a> and <a href="/pmc/articles/PMC3607698/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and8</span></span><span>8</span></a>).</p><p id="__p49" class="p p-last">In summary, the effect of the variant SNP genotypes that we observed in or near <em>TSPYL5</em> in postmenopausal women is to increase the level of TSPYL5 expression in response to E2, as well as downstream, CYP19A1 expression, resulting in increased biosynthesis of E2 and increased circulating levels of E2, ie., a positive feedback loop. These results not only provide insight into a novel genomic mechanism for the regulation of aromatase gene expression and, thus, plasma E2 concentrations in postmenopausal women with ER(+) breast cancer, but they also raise the possibility of a novel role for TSPYL5 as a transcription factor that can influence the expression of many genes (see <a href="/pmc/articles/PMC3607698/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>) other than <em>CYP19A1</em>.</p></div><div id="idm140707392841792" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140707392841792title">Acknowledgments</h2><div class="sec"><p id="__p70">This work was supported, in part, by National Institutes of Health Grants <span>U19 GM61388</span> (The Pharmacogenomics Research Network-The RIKEN Center for Genomic Medicine (CGM) Global Alliance, <span>R01 GM28157</span>;, <span>U01 HG005137</span>;, <span>R01 CA138461</span>;, <span>R01 CA133049</span>;, <span>P50 CA166201</span> (Mayo Clinic Breast Cancer Specialized Program of Research Excellence), a PhRMA Foundation Center of Excellence in Clinical Pharmacology Award, and a generous gift from the Atwater Foundation, <a href="http://ClinicalTrials.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">ClinicalTrials.gov</a> study number <span><a id="__tag_540133422" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00283608" ref="reftype=extlink-clinical-trial&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00283608","term_id":"NCT00283608"}}</span>NCT00283608</a></span>.</p><p id="__p71">Current address for B.L.F.: Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas 66160.</p><p id="__p72">Disclosure Summary: The authors have no conflict of interest.</p></div></div><div id="idm140707460785072" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140707460785072title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140707460784704"></p><p id="__p50" class="p p-first-last">Abbreviations:
</p><div class="def-list"><dl class="labeled-list"><dt id="G1">BMI</dt><dd>body mass index</dd><dt id="G2">ChIP</dt><dd>chromatin immunoprecipitation</dd><dt id="G3">E2</dt><dd>estradiol</dd><dt id="G4">ER</dt><dd>estrogen receptor</dd><dt id="G5">ERE</dt><dd>estrogen response element</dd><dt id="G6">FBS</dt><dd>fetal bovine serum</dd><dt id="G7">GC-MS/MS</dt><dd>gas chromatography negative ionization tandem mass spectrometry</dd><dt id="G8">GWAS</dt><dd>genome-wide association study</dd><dt id="G9">HEK</dt><dd>human embryonic kidney</dd><dt id="G10">LCL</dt><dd>lymphoblastoid cell line</dd><dt id="G11">LLQ</dt><dd>lower limit of quantitation</dd><dt id="G12">MAF</dt><dd>minor allele frequency</dd><dt id="G13">PgR</dt><dd>progesterone receptor</dd><dt id="G14">QC</dt><dd>quality control</dd><dt id="G15">qRT-PCR</dt><dd>quantitative RT-PCR</dd><dt id="G16">siRNA</dt><dd>small interfering RNA</dd><dt id="G17">SNP</dt><dd>single nucleotide polymorphism</dd><dt id="G18">UTR</dt><dd>untranslated region</dd><dt id="G19">WT</dt><dd>wild type.</dd></dl></div><p></p><p></p></div></div><div id="idm140707461202976" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140707461202976title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="mixed-citation">
Ingle JN, Buzdar AU, Schaid DJ, et al. 
<span class="ref-title">Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer</span>. <span class="ref-journal">Cancer Res</span>. 2010;<span class="ref-vol">70</span>:3278–3286 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2855746/">PMC free article</a>]</span> [<a href="/pubmed/20354183" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Variation+in+anastrozole+metabolism+and+pharmacodynamics+in+women+with+early+breast+cancer&amp;author=JN+Ingle&amp;author=AU+Buzdar&amp;author=DJ+Schaid&amp;volume=70&amp;publication_year=2010&amp;pages=3278-3286&amp;pmid=20354183&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="mixed-citation">
Neven P.
<span class="ref-title">The origin of postmenopausal oestrogens</span>. <span class="ref-journal">Eur J Cancer</span>. 2002;<span class="ref-vol">38</span>(<span class="ref-iss">suppl 6</span>):S29–S30 [<a href="/pubmed/12409064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer&amp;title=The+origin+of+postmenopausal+oestrogens&amp;author=P+Neven&amp;volume=38&amp;issue=suppl+6&amp;publication_year=2002&amp;pages=S29-S30&amp;pmid=12409064&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="mixed-citation">
Schuit SC, de Jong FH, Stolk L, et al. 
<span class="ref-title">Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women</span>. <span class="ref-journal">Eur J Endocrinol</span>. 2005;<span class="ref-vol">153</span>:327–334 [<a href="/pubmed/16061840" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Endocrinol&amp;title=Estrogen+receptor+alpha+gene+polymorphisms+are+associated+with+estradiol+levels+in+postmenopausal+women&amp;author=SC+Schuit&amp;author=FH+de+Jong&amp;author=L+Stolk&amp;volume=153&amp;publication_year=2005&amp;pages=327-334&amp;pmid=16061840&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="mixed-citation">
Lucisano A, Acampora MG, Russo N, Maniccia E, Montemurro A, Dell'Acqua S.
<span class="ref-title">Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women</span>. <span class="ref-journal">Maturitas</span>. 1984;<span class="ref-vol">6</span>:45–53 [<a href="/pubmed/6472127" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Maturitas&amp;title=Ovarian+and+peripheral+plasma+levels+of+progestogens,+androgens+and+oestrogens+in+post-menopausal+women&amp;author=A+Lucisano&amp;author=MG+Acampora&amp;author=N+Russo&amp;author=E+Maniccia&amp;author=A+Montemurro&amp;volume=6&amp;publication_year=1984&amp;pages=45-53&amp;pmid=6472127&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="mixed-citation">
Kinoshita Y, Chen S.
<span class="ref-title">Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha</span>. <span class="ref-journal">Cancer Res</span>. 2003;<span class="ref-vol">63</span>:3546–3555 [<a href="/pubmed/12839940" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Induction+of+aromatase+(CYP19)+expression+in+breast+cancer+cells+through+a+nongenomic+action+of+estrogen+receptor+alpha&amp;author=Y+Kinoshita&amp;author=S+Chen&amp;volume=63&amp;publication_year=2003&amp;pages=3546-3555&amp;pmid=12839940&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="mixed-citation">
Simpson ER, Mahendroo MS, Means GD, et al. 
<span class="ref-title">Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis</span>. <span class="ref-journal">Endocr Rev</span>. 1994;<span class="ref-vol">15</span>:342–355 [<a href="/pubmed/8076586" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;title=Aromatase+cytochrome+P450,+the+enzyme+responsible+for+estrogen+biosynthesis&amp;author=ER+Simpson&amp;author=MS+Mahendroo&amp;author=GD+Means&amp;volume=15&amp;publication_year=1994&amp;pages=342-355&amp;pmid=8076586&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="mixed-citation">
Shozu M, Akasofu K, Harada T, Kubota Y.
<span class="ref-title">A new cause of female pseudohermaphroditism: placental aromatase deficiency</span>. <span class="ref-journal">J Clin Endocrinol Metab</span>. 1991;<span class="ref-vol">72</span>:560–566 [<a href="/pubmed/1825497" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=A+new+cause+of+female+pseudohermaphroditism:+placental+aromatase+deficiency&amp;author=M+Shozu&amp;author=K+Akasofu&amp;author=T+Harada&amp;author=Y+Kubota&amp;volume=72&amp;publication_year=1991&amp;pages=560-566&amp;pmid=1825497&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="mixed-citation">
Wang L, Ellsworth KA, Moon I, et al. 
<span class="ref-title">Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors</span>. <span class="ref-journal">Cancer Res</span>. 2010;<span class="ref-vol">70</span>:319–328 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2804935/">PMC free article</a>]</span> [<a href="/pubmed/20048079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Functional+genetic+polymorphisms+in+the+aromatase+gene+CYP19+vary+the+response+of+breast+cancer+patients+to+neoadjuvant+therapy+with+aromatase+inhibitors&amp;author=L+Wang&amp;author=KA+Ellsworth&amp;author=I+Moon&amp;volume=70&amp;publication_year=2010&amp;pages=319-328&amp;pmid=20048079&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="mixed-citation">
Epping MT, Meijer LA, Krijgsman O, Bos JL, Pandolfi PP, Bernards R.
<span class="ref-title">TSPYL5 suppresses p53 levels and function by physical interaction with USP7</span>. <span class="ref-journal">Nat Cell Biol</span>. 2011;<span class="ref-vol">13</span>:102–108 [<a href="/pubmed/21170034" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Cell+Biol&amp;title=TSPYL5+suppresses+p53+levels+and+function+by+physical+interaction+with+USP7&amp;author=MT+Epping&amp;author=LA+Meijer&amp;author=O+Krijgsman&amp;author=JL+Bos&amp;author=PP+Pandolfi&amp;volume=13&amp;publication_year=2011&amp;pages=102-108&amp;pmid=21170034&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="mixed-citation">
Li L, Fridley B, Kalari K, et al. 
<span class="ref-title">Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression</span>. <span class="ref-journal">Cancer Res</span>. 2008;<span class="ref-vol">68</span>:7050–7058 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2562356/">PMC free article</a>]</span> [<a href="/pubmed/18757419" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Gemcitabine+and+cytosine+arabinoside+cytotoxicity:+association+with+lymphoblastoid+cell+expression&amp;author=L+Li&amp;author=B+Fridley&amp;author=K+Kalari&amp;volume=68&amp;publication_year=2008&amp;pages=7050-7058&amp;pmid=18757419&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="mixed-citation">
Ingle JN, Schaid DJ, Goss PE, et al. 
<span class="ref-title">Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors</span>. <span class="ref-journal">J Clin Oncol</span>. 2010;<span class="ref-vol">28</span>:4674–4682 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3020700/">PMC free article</a>]</span> [<a href="/pubmed/20876420" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Genome-wide+associations+and+functional+genomic+studies+of+musculoskeletal+adverse+events+in+women+receiving+aromatase+inhibitors&amp;author=JN+Ingle&amp;author=DJ+Schaid&amp;author=PE+Goss&amp;volume=28&amp;publication_year=2010&amp;pages=4674-4682&amp;pmid=20876420&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="mixed-citation">
Prokai-Tatrai K, Bonds D, Prokai L.
<span class="ref-title">Simultaneous measurement of 17β-estradiol, 17α-estradiol and estrone by GC-isotope dilution MS/MS</span>. <span class="ref-journal">Chromatographia</span>. 2010;<span class="ref-vol">71</span>:311–315 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2901118/">PMC free article</a>]</span> [<a href="/pubmed/20625535" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chromatographia&amp;title=Simultaneous+measurement+of+17β-estradiol,+17α-estradiol+and+estrone+by+GC-isotope+dilution+MS/MS&amp;author=K+Prokai-Tatrai&amp;author=D+Bonds&amp;author=L+Prokai&amp;volume=71&amp;publication_year=2010&amp;pages=311-315&amp;pmid=20625535&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="mixed-citation">
Pritchard JK, Stephens M, Donnelly P.
<span class="ref-title">Inference of population structure using multilocus genotype data</span>. <span class="ref-journal">Genetics</span>. 2000;<span class="ref-vol">155</span>:945–959 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1461096/">PMC free article</a>]</span> [<a href="/pubmed/10835412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Inference+of+population+structure+using+multilocus+genotype+data&amp;author=JK+Pritchard&amp;author=M+Stephens&amp;author=P+Donnelly&amp;volume=155&amp;publication_year=2000&amp;pages=945-959&amp;pmid=10835412&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="mixed-citation">
Niu N, Qin Y, Fridley BL, et al. 
<span class="ref-title">Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines</span>. <span class="ref-journal">Genome Res</span>. 2010;<span class="ref-vol">20</span>:1482–1492 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2963812/">PMC free article</a>]</span> [<a href="/pubmed/20923822" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Radiation+pharmacogenomics:+a+genome-wide+association+approach+to+identify+radiation+response+biomarkers+using+human+lymphoblastoid+cell+lines&amp;author=N+Niu&amp;author=Y+Qin&amp;author=BL+Fridley&amp;volume=20&amp;publication_year=2010&amp;pages=1482-1492&amp;pmid=20923822&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="mixed-citation">
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D.
<span class="ref-title">Principal components analysis corrects for stratification in genome-wide association studies</span>. <span class="ref-journal">Nat Genet</span>. 2006;<span class="ref-vol">38</span>:904–909 [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=AL+Price&amp;author=NJ+Patterson&amp;author=RM+Plenge&amp;author=ME+Weinblatt&amp;author=NA+Shadick&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="mixed-citation">
Patterson N, Price AL, Reich D.
<span class="ref-title">Population structure and eigenanalysis</span>. <span class="ref-journal">PLoS Genet</span>. 2006;<span class="ref-vol">2</span>:e190. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1713260/">PMC free article</a>]</span> [<a href="/pubmed/17194218" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Population+structure+and+eigenanalysis&amp;author=N+Patterson&amp;author=AL+Price&amp;author=D+Reich&amp;volume=2&amp;publication_year=2006&amp;pages=e190&amp;pmid=17194218&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="mixed-citation">
Endogenous Hormones Breast Cancer Collaborative Group
<span class="ref-title">Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women</span>. <span class="ref-journal">J Natl Cancer Inst</span>. 2003;<span class="ref-vol">95</span>:1218–1226 [<a href="/pubmed/12928347" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Body+mass+index,+serum+sex+hormones,+and+breast+cancer+risk+in+postmenopausal+women&amp;volume=95&amp;publication_year=2003&amp;pages=1218-1226&amp;pmid=12928347&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="mixed-citation">
Wedderburn RWM.
<span class="ref-title">Quasi-likelihood functions, generalized linear models, and the Gauss-Newton method</span>. <span class="ref-journal">Biometrika</span>. 1974;<span class="ref-vol">61</span>:439–447 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biometrika&amp;title=Quasi-likelihood+functions,+generalized+linear+models,+and+the+Gauss-Newton+method&amp;author=RWM+Wedderburn&amp;volume=61&amp;publication_year=1974&amp;pages=439-447&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="mixed-citation">
Agresti A.
2002. 
<span class="ref-journal">Categorical Data Analysis</span>. Hoboken, NJ: John Wiley, Sons, Inc <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Categorical+Data+Analysis&amp;author=A+Agresti&amp;publication_year=2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="mixed-citation">
Purcell S, Neale B, Todd-Brown K, et al. 
<span class="ref-title">PLINK: A tool set for whole-genome association and population-based linkage analyses</span>. <span class="ref-journal">Am J Hum Genet</span>. 2007;<span class="ref-vol">81</span>:559–575 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+A+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;volume=81&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="mixed-citation">
Browning BL, Browning SR.
<span class="ref-title">A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals</span>. <span class="ref-journal">Am J Hum Genet</span>. 2009;<span class="ref-vol">84</span>:210–223 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2668004/">PMC free article</a>]</span> [<a href="/pubmed/19200528" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=A+unified+approach+to+genotype+imputation+and+haplotype-phase+inference+for+large+data+sets+of+trios+and+unrelated+individuals&amp;author=BL+Browning&amp;author=SR+Browning&amp;volume=84&amp;publication_year=2009&amp;pages=210-223&amp;pmid=19200528&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="mixed-citation">
Durbin RM, Abecasis GR, Altshuler DL, et al.  <span class="ref-title">A map of human genome variation from population-scale sequencing</span>. <span class="ref-journal">Nature</span>. 2010;<span class="ref-vol">467</span>:1061–1073 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3042601/">PMC free article</a>]</span> [<a href="/pubmed/20981092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+map+of+human+genome+variation+from+population-scale+sequencing&amp;author=RM+Durbin&amp;author=GR+Abecasis&amp;author=DL+Altshuler&amp;volume=467&amp;publication_year=2010&amp;pages=1061-1073&amp;pmid=20981092&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="mixed-citation">
Hui J, Gu YF, Wu XM, et al. 
<span class="ref-title">Defibrillation efficacy of a newly developed automated external defibrillator in a swine ventricular tachycardia/fibrillation model</span>. <span class="ref-journal">Zhonghua Xin Xue Guan Bing Za Zhi</span>. 2009;<span class="ref-vol">37</span>:845–848 [<a href="/pubmed/20128387" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Zhonghua+Xin+Xue+Guan+Bing+Za+Zhi&amp;title=Defibrillation+efficacy+of+a+newly+developed+automated+external+defibrillator+in+a+swine+ventricular+tachycardia/fibrillation+model&amp;author=J+Hui&amp;author=YF+Gu&amp;author=XM+Wu&amp;volume=37&amp;publication_year=2009&amp;pages=845-848&amp;pmid=20128387&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="mixed-citation">
Hoppenbrouwers IA, Aulchenko YS, Janssens AC, et al. 
<span class="ref-title">Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis</span>. <span class="ref-journal">J Hum Genet</span>. 2009;<span class="ref-vol">54</span>:676–680 [<a href="/pubmed/19834503" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hum+Genet&amp;title=Replication+of+CD58+and+CLEC16A+as+genome-wide+significant+risk+genes+for+multiple+sclerosis&amp;author=IA+Hoppenbrouwers&amp;author=YS+Aulchenko&amp;author=AC+Janssens&amp;volume=54&amp;publication_year=2009&amp;pages=676-680&amp;pmid=19834503&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="mixed-citation">
Yang J, Weedon MN, Purcell S, et al. 
<span class="ref-title">Genomic inflation factors under polygenic inheritance</span>. <span class="ref-journal">Eur J Hum Genet</span>. 2011;<span class="ref-vol">19</span>:807–812 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3137506/">PMC free article</a>]</span> [<a href="/pubmed/21407268" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Hum+Genet&amp;title=Genomic+inflation+factors+under+polygenic+inheritance&amp;author=J+Yang&amp;author=MN+Weedon&amp;author=S+Purcell&amp;volume=19&amp;publication_year=2011&amp;pages=807-812&amp;pmid=21407268&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="mixed-citation">
Montserrat N, Gonzalez A, Mendez E, Piferrer F, Planas JV.
<span class="ref-title">Effects of follicle stimulating hormone on estradiol-17 β production and P-450 aromatase (CYP19) activity and mRNA expression in brown trout vitellogenic ovarian follicles in vitro</span>. <span class="ref-journal">Gen Comp Endocrinol</span>. 2004;<span class="ref-vol">137</span>:123–131 [<a href="/pubmed/15158124" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gen+Comp+Endocrinol&amp;title=Effects+of+follicle+stimulating+hormone+on+estradiol-17+β+production+and+P-450+aromatase+(CYP19)+activity+and+mRNA+expression+in+brown+trout+vitellogenic+ovarian+follicles+in+vitro&amp;author=N+Montserrat&amp;author=A+Gonzalez&amp;author=E+Mendez&amp;author=F+Piferrer&amp;author=JV+Planas&amp;volume=137&amp;publication_year=2004&amp;pages=123-131&amp;pmid=15158124&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="mixed-citation">
Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M.
<span class="ref-title">The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters</span>. <span class="ref-journal">J Steroid Biochem Mol Biol</span>. 2003;<span class="ref-vol">86</span>:219–224 [<a href="/pubmed/14623514" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Steroid+Biochem+Mol+Biol&amp;title=The+human+CYP19+(aromatase+P450)+gene:+update+on+physiologic+roles+and+genomic+organization+of+promoters&amp;author=SE+Bulun&amp;author=S+Sebastian&amp;author=K+Takayama&amp;author=T+Suzuki&amp;author=H+Sasano&amp;volume=86&amp;publication_year=2003&amp;pages=219-224&amp;pmid=14623514&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="mixed-citation">
Cheong YH, Moon BC, Kim JK, et al. 
<span class="ref-title">BWMK1, a rice mitogen-activated protein kinase, locates in the nucleus and mediates pathogenesis-related gene expression by activation of a transcription factor</span>. <span class="ref-journal">Plant Physiol</span>. 2003;<span class="ref-vol">132</span>:1961–1972 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC181281/">PMC free article</a>]</span> [<a href="/pubmed/12913152" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Plant+Physiol&amp;title=BWMK1,+a+rice+mitogen-activated+protein+kinase,+locates+in+the+nucleus+and+mediates+pathogenesis-related+gene+expression+by+activation+of+a+transcription+factor&amp;author=YH+Cheong&amp;author=BC+Moon&amp;author=JK+Kim&amp;volume=132&amp;publication_year=2003&amp;pages=1961-1972&amp;pmid=12913152&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="mixed-citation">
Zhou DJ, Pompon D, Chen SA.
<span class="ref-title">Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening</span>. <span class="ref-journal">Cancer Res</span>. 1990;<span class="ref-vol">50</span>:6949–6954 [<a href="/pubmed/2208160" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Stable+expression+of+human+aromatase+complementary+DNA+in+mammalian+cells:+a+useful+system+for+aromatase+inhibitor+screening&amp;author=DJ+Zhou&amp;author=D+Pompon&amp;author=SA+Chen&amp;volume=50&amp;publication_year=1990&amp;pages=6949-6954&amp;pmid=2208160&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="mixed-citation">
Nakata T, Takashima S, Shiotsu Y, et al. 
<span class="ref-title">Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients</span>. <span class="ref-journal">J Steroid Biochem Mol Biol</span>. 2003;<span class="ref-vol">86</span>:455–460 [<a href="/pubmed/14623544" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Steroid+Biochem+Mol+Biol&amp;title=Role+of+steroid+sulfatase+in+local+formation+of+estrogen+in+post-menopausal+breast+cancer+patients&amp;author=T+Nakata&amp;author=S+Takashima&amp;author=Y+Shiotsu&amp;volume=86&amp;publication_year=2003&amp;pages=455-460&amp;pmid=14623544&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="mixed-citation">
Kublickiene K, Fu XD, Svedas E, Landgren BM, Genazzani AR, Simoncini T.
<span class="ref-title">Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement</span>. <span class="ref-journal">J Clin Endocrinol Metab</span>. 2008;<span class="ref-vol">93</span>:1874–1883 [<a href="/pubmed/18319309" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Effects+in+postmenopausal+women+of+estradiol+and+medroxyprogesterone+alone+and+combined+on+resistance+artery+function+and+endothelial+morphology+and+movement&amp;author=K+Kublickiene&amp;author=XD+Fu&amp;author=E+Svedas&amp;author=BM+Landgren&amp;author=AR+Genazzani&amp;volume=93&amp;publication_year=2008&amp;pages=1874-1883&amp;pmid=18319309&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="mixed-citation">
Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. 
<span class="ref-title">A prospective study of endogenous estrogens and breast cancer in postmenopausal women</span>. <span class="ref-journal">J Natl Cancer Inst</span>. 1995;<span class="ref-vol">87</span>:190–197 [<a href="/pubmed/7707406" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=A+prospective+study+of+endogenous+estrogens+and+breast+cancer+in+postmenopausal+women&amp;author=PG+Toniolo&amp;author=M+Levitz&amp;author=A+Zeleniuch-Jacquotte&amp;volume=87&amp;publication_year=1995&amp;pages=190-197&amp;pmid=7707406&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3607698&amp;issue-id=221068&amp;journal-id=563&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm140707427392976title">Abstract</a></li><li><a href="#__sec1title">Materials and Methods</a></li><li><a href="#__sec13title">Results</a></li><li><a href="#__sec19title">Discussion</a></li><li><a href="#idm140707392841792title">Acknowledgments</a></li><li><a href="#idm140707460785072title">Footnotes</a></li><li><a href="#idm140707461202976title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Molecular Endocrinology</span> are provided here courtesy of <strong>The Endocrine Society</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3607698/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3607698/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3607698/?report=printable">Printer Friendly</a></li> | <li><a href="#" data-citationid="PMC3607698" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3607698%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3607698%2F&amp;text=TSPYL5%20SNPs%3A%20Association%20with%20Plasma%20Estradiol%20Concentrations%20and%20Aromatase%20Expression" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3607698%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23518928" data-aiid="3607698" data-aid="3607698" data-iid="221068" data-domainid="563" data-domain="mend" data-accid="PMC3607698" data-md5="8208446f2a7c005e86ed44eb3d18ba62"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T10:31:36-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal101&amp;ncbi_phid=CE888363DD555BD100000000055D0371&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3607698%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=mend&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3607698/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>